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THE DANGERS OF PSYCHOTROPIC MEDICATION FOR
MENTALL Y ILL CHILDREN: WHERE IS THE CHILD'S
VOICE IN CONSENTING TO MEDICATION? AN
EMPIRICAL STUDY
by DONALD H. STONE *
INTRODUCTION

When a child with a mental illness is being prescribed psychotropic
medication, who decides whether the child should take the medication-the parent
or the child? What if the child is sixteen years of age? What if the child is in foster
care: Should the parent or social service agency decide? Prior to administering
psychotropic medication, what specific information should be provided to the
person authorized to consent on behalf of the child? Should children be permitted
to refuse psychotropic medications? If so, at what age should a child be able to
refuse such medication? What procedures should be put in place to forcibly
medicate a child with psychotropic medication?
There are numerous reports indicating that children in foster care are
overmedicated as compared to children not in foster care. I What are the reasons for
this occurrence? Are there abuses within the foster care system? Should the state
mental health agency monitor psychotropic medications for children, require
oversight or a second opinion, or monitor abuse? What authority should a state
agency have to stop prescribing psychotropic medication to children?
This article will explore the overmedication of children with mental illness,
with a specific emphasis on foster care children. Part I will examine the use of
psychotropic medication on children, from the viewpoint of psychiatrists,
pediatricians, parents, and children. 2 Part II will explore the reasons why foster
children receive psychotropic medications at a higher rate than children under their
parents' care. 3 Part III will provide an explanation of the consent procedures for
children, and a critical inquiry into the manner psychiatrists and psychiatric

* Donald H. Stone, Professor of Law at the University of Baltimore School of Law, B.A., Rutgers
University, J.D., Temple University School of Law. I gratefully acknowledge my research assistant,
Abby C. Boyd, a 2014 graduate of the University of Baltimore School of Law. In addition, special
thanks to Dr. Erik Roskes, Clinical Director, Forensic Services, Springfield Hospital Center, for his
insight, advice, and assistance in the discussions we had on the mentally ill child.
I. See Julie M. Zito et aI., Psychotropic Medication Patterns Among Youth in Foster Care, 121
PEDIATRICS e1S7, el62 (2008) (expressing doubts about "whether the dispensing of :::3 different
psychotropic medication classes concomitantly to children in foster care represents a treatment
advantage").
2. See infra Part I (examining the viewpoints of psychiatrists, pediatricians, parents, and children).
3. See infra Part II (considering why foster children receive psychotropic medications at a higher
rate than other children).
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hospitals undertake to address a minor's refusal to take psychotropic medication. 4
Additionally, Part I will analyze various states' responses to addressing both
the overmedicating of children as well as consent and refusal issues that ultimately
result from the medication of children. s It will offer recommendations for a model
consent form to be utilized by psychiatrists and in-patient psychiatric hospitals. 6 It
will present the rights of children to refuse psychotropic medication as
recommended, and the procedure for overriding such refusal. 7
Finally, Part III will analyze a survey of psychiatrists and pediatricians on the
use of psychotropic medications to understand the existing consent procedures
governing a minor's refusal to take psychotropic medications. 8 The survey's design
allows for a better understanding of the reasons behind the overmedication of foster
children. The analysis will highlight the best practices and offer recommendations
that provide for a state reporting and monitoring system.
I. ISSUES OF CONSENT: THE ROLE OF THE CHILD IN HIS OWN MEDICAL DECISIONS

A. The Parent, the State as Parents Patraie, or the Child: When is a Minor
Medicated, and Who Decides?

Should children of a certain age be authorized to consent or refuse
psychotropic medication? The legal system, for the most part, has set the age of
consent as the age of majority (age eighteen).9 However, the significant and
intrusive nature of psychotropic medication justifies changing this determinative
age.1O The mature minor should be permitted a voice in the decision-making
process of this meaningful and life-altering event. II
In another area where decisions are made about a child's medical care, a
minor's choice to have an abortion, the U.S. Supreme Court has evaluated the
rights of parents to be notified prior to the procedure being performed on a minor. 12
In Hodgson v. Minnesota,B a statute requiring a parent's consent for a minor's

4. See infra Part III (explaining consent procedures for children and inquiring into how
psychiatrists and psychiatric hospitals address a minor's refusal to take psychotropic medication).
5. See infra Part I.C (analyzing how states address the overmedicating of children and ability to
consent).
6. See infra notes 189-215 and accompanying text (recommending a model consent form).
7. See infra Part 1.8-0 (recommending the rights of children to refuse psychotropic medication and
the procedure for overriding such refusal).
8. See infra Part III (analyzing a survey of psychiatrists and pediatricians on the use of
psychotropic medications).
9. Kimberly M. Mutcherson, Whose Body Is It Anyway? An Updated Model of Healthcare
Decision-Making Rights for Adolescents, 14 CORNELL J.L. & PUB. POL'y 251,259 (2005).
10. See Jennifer Albright, Free Your Mind: The Right of Minors in New York to Choose Whether or
Not to Be Treated with Psychotropic Drugs, 16 ALB. L.J. SCI. & TECH. 169, 177 (2006) ("A minor who
can exercise adult judgment should be able to give consent to psychotropic medication.").
II. See id. at 178 ("Given the known adverse side effects and still unknown permanent effects,
minors should be allowed to participate in the decision whether or not to take psychotropic
medications.").
12. Hodgson v. Minnesota, 497 U.S. 417,449 (I 990}.
13. 497 U.S. 417 (1990).
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abortion was evaluated through the traditional common law perspective of
requiring parental consent for any medical procedure performed on minors.14 The
Court held that in certain cases, a minor need not receive consent from a parent to
obtain the medical procedure. '5 The autonomy of the minor's right to consent or
refuse psychotropic medication should be viewed as akin to other significant
medical decisions which recognize their authority. 16
Similarly, in Planned Parenthood of Central Missouri v. Danforth,17 the
Supreme Court acknowledged that the ability to make good decisions does not
come into being as soon as one attains the state-defined age of majority. IS The
Court has likened this to other areas of a child's decision making, such as
undergoing an operation, marrying, or entering military service, and the Court
noted that parental consent is often needed to counter the immaturity, inexperience,
and lack of judgment that impairs the ability of a minor to exercise her rights
wisely.'9 However, the Court has also acknowledged that for certain minors, a
judicial bypass as an alternative to parental consent, at least for obtaining an
abortion, should be available where a minor may demonstrate that she 1S
sufficiently mature, despite her age, to make the decision herself. 20
The Court in Hodgson recognized that the "mature minor" is capable of
making the important and significant decision to obtain an abortion. 21 Courts should
similarly respect these mature minors enough to allow them to make significant
decisions in other areas, such as medication refusal. 22 Medicating a minor with
psychotropic drugs, as compared with decisions regarding marriage and enlisting in
the military, is different due to the intrusive nature of forcing mind-altering drugs
onto one's own person. 23 A minor's right to his own bodily integrity should be
respected. 24 A minor's desire to avoid being forcibly medicated should be

14. Id. at 422-23.
15. Id.
16. See id. (upholding a statute authorizing a minor to give effective consent without parental
involvement for treatment of pregnancy and complications associated with venereal disease, alcohol,
and drug abuse).
17. 428 U.S. 52 (1976).
18. See id. at 74 ("Constitutional rights do not mature and come into being magically only when one
attains the state-defined age majority. ").
19. Bellotti v. Baird, 443 U.S. 622, 634-39 (1979).
20. Hodgson, 487 U.S. at 455 (permitting the minor to demonstrate the abortion is in her best
interest).
21. [d. at 430.
22. See Jennifer L. Rosato, The Ultimate Test of Autonomy: Should Minors Have A Right to Make
Decisions Regarding Life-Sustaining Treatment?, 49 RUTGERS L. REV. I, 5 (1996) ("In most
circumstances, mature minors should be able to make life-sustaining treatment decisions themselves.
Age should not impose an artificial barrier to a minor's right to self-determination.").
23. Myers v. Alaska Psychiatric Ins!., 138 P.3d 238, 242 (Alaska 2006) ("[T]he truly intrusive
nature of psychotropic drugs may be best understood by appreciating that they are literally intended to
alter the mind. Recognizing that purpose, many states have equated the intrusiveness of psychotropic
medication with the intrusiveness of electroconvulsive therapy and psychosurgery.").
24. See Dennis E. Cichon, The Right to "Just Say No ": A History and Analysis of the Right 10
Refuse Antipsychotic Drugs, 53 LA. L. REV. 283, 377 (1992) ("[A ]ntipsychotic drugs are much more
intrusive than temporary physical restraints, encroaching upon bodily integrity and personal security to a
far greater degree. ").
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acknowledged. 25 A minor should be permitted to stand pat and prohibit the
intrusive nature of psychotropic medication over the objection of her doctor.2 6
There are often competing interests involved in the health and welfare of
childrenY Parents are used to addressing and providing for the well-being of their
minor children. 28 Because of this, the state intervenes only if the parents' decisionmaking and actions undermine the child's best interests. 29 Unfortunately, the rights
and responsibilities of a minor child in consenting to important matters affecting
his own health and safety is so often an afterthought. 30 The autonomy of a mature
minor, independent of the parents, should be acknowledgedY
In the landmark u.s. Supreme Court case Wisconsin v. Yoder,32 the rights of
parents conflicted with the responsibility of the state over Wisconsin's compulsory
education law. 33 The Court addressed the power of the state as parens patriae to
require secondary education for children against the wishes of their Amish
parents. 34 Finding no demonstration of harm to the physical or mental health of the
child, or threat to public safety or welfare, the Court held that the rights of the
parents trumped the important state interest in creating an educated citizenry.35
Interestingly, the dissent in Yoder highlights an important, albeit unresolved, issue
as to what happens if the child's wishes conflict with the parent's wishes regarding
school attendance. 36 Similar conflicts occur if the state, parent, and minor child do
not agree over whether psychotropic medication should be prescribed. 37
In Sombrotto v. Christiana W,38 a New York state court examined the rights
of parents to object to a hospital's petition to involuntarily administer psychotropic

25. See Susan D. Hawkins, Protecting the Rights and Interests of Competent Minors in Litigated
Medical Treatment Disputes, 64 FORDHAM L. REv. 2075,2077 (1996) ("[A] competent minor's right to
make certain medical decisions for herself should receive protection .... ").
26. See id. at 2077 ("If a minor has the right to choose to undergo such an invasive procedure as an
abortion, then certainly she should have the right to refuse or accept other forms of medical treatment on
her own behalf.").
27. See id. at 2080-90 (examining the respective interests of parents and the state in medical
treatment cases in an effort to explain why, traditionally, a minor's parents and the state have been the
only parties who have enjoyed standing in such cases).
28. See id. at 2075 ("Parents generally have the sole authority to decide whether their children will
receive such treatment, and a physician may not treat a minor without the consent of the minor's parent
or guardian.").
29. See id. at 2086 ("Even though the child's interests are at stake in medical treatment cases, courts
tend to consider only the parents' and the state's interests in the outcome.").
30. See id. ("The interests of the child are deemed secondary, if considered at all.").
31. See Hawkins, supra note 25, at 2132 ("Courts in litigated medical treatment disputes must
recognize that competent minors have rights and interests, apart from those of their parents and the state,
that require protection.").
32. 406 U.S. 205 (1972).
33. Id. at 207-09.
34. Id. at 229-34.
35. Id. at 230, 234.
36. Id. at 244-46.
37. See Albright, supra note 10, at 189-90 ("Some parents may consent, or refuse consent, to the use
of psychotropic drugs for their children based on religious or moral beliefs.").
38. 852 N.Y.S.2d 57 (N.Y. App. Div. 2008).
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medication to their fourteen-year-old child. 39 The court recognized, on the basis of
state law, that either the consent of a parent or guardian or the authorization of a
court is required for the non-emergency administration of psychotropic medication
to a minor residing in a hospital. 40 The court held that great deference must be
accorded to a parent's choice as to the mode of medical treatment to be undertaken
and the physician selected to administer the law. 4I
The Sombrotto court acknowledged that even when the parent's decision to
decline necessary treatment is based on constitutional grounds, it must yield to the
state as parens patriae if the parent's decision poses a threat to the health and
welfare of the child. 42 However, there was no evidence presented that the child was
suffering from a life-threatening condition, no negative side effects were present,
and no long-term life-enhancing benefit to prescribing the medication over the
parent's objection.43 Accordingly, the parent's decision trumped the state's desire. 44
While parents generally have a constitutional right to make medical decisions
for their children, this changes if the parents are unfit. 45 When children are
neglected and placed in the care of a social services agency, the rights of parents to
provide consent for the administration of psychotropic medication are called into
question. 46 The District of Columbia Court of Appeals addressed this issue in In re
G.K.,47 a case of first impression. 48 In determining whether the Child and Family
Services Agency ("CFSA") had authorization to provide consent for the
administration of psychotropic medication, the court focused on the significance of
psychotropic medication. The court did not look to whether the administration was
39. Id. at 58 ("[A]fter conducting a hearing to which the parents were not parties.").

40. Id. at 60-61 (relying on an Article 10 of the Family Court Act); see also Matter of Bennett v.
Jeffreys, 40 N.Y.2d 543, 546 (1976) (acknowledging that every parent has a fundamental right to raise
his child).
41. Sombrotto, 852 N'y.S.2d at 62.
42. Id. at 63; see also In re W.H., 25 A.3d. 330, 337 (Pa. Super. Ct. 2011) (setting forth the
procedures to obtain a court-ordered consent for medical treatment for children under legal custody of
the county department of public welfare).
43. Sombrotto, 852 N.Y.S.2d at 63; see also Rivers v. Katz, 67 N.Y.2d 485, 497-98 (1986) (setting
forth the standard of proof as clear and convincing evidence that psychotropic medication was
warranted).
44. Sombrotto, 852 N.Y.S.2d at 63-64.
45. See Maska v. Maska, 742 N.W.2d 492, 497 (Neb. 2007) (affirming a district court's order that
because each parent was fit, "each parent was allowed to make medical decisions on an emergency basis
for the benefit of the children when the children were in his or her physical custody"); J.W.J., Jr. v.
P.K.R., 999 So. 2d 943, 951-52 (Ala. Civ. App. 2008) (holding that a fit parent can make medical
decisions regarding his child); State ex reI. Juvenile Dep't of Multnomah Cnty. v. Smith, 133 P.3d 924,
930 (Or. Ct. App. 2006) (holding that mother had not become sufficiently educated or involved in either
minor's life or her treatment to be qualified to make decisions regarding minor's medical care).
46. See JOANNE SOLCHANY, A.B.A. CTR. ON CHILD. AND THE LAW, PSYCHOTROPIC MEDICATION
AND CHILDREN IN FOSTER CARE: TIPS FOR ADVOCATES AND JUDGES 18 (Claire Sandt Chiamulera ed.,
2011) (stating that for children in foster care, it is the state or children's administration, the foster parent
caring for the child, or the courts that may have the authority to consent to medication for children in
foster care).
47. 993 A.2d 558 (D.C. 2010).
48. Id. at 559 (analyzing the situation ofa child placed in the care of the District of Columbia Child
and Family Services Agency by the court in order to decide whether to authorize in-patient psychotropic
medication for the child).
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within the course of ordinary medical care. 49 Instead, it held that psychotropic
medication was a much more invasive medical treatment that would require
additional consent. 50 Whether a neglected child is prescribed psychotropic
medication is "presumptively within the ambit of residual parental rights-subject
to the Family Court's responsibility as parens patriae: to intervene, if necessary, to
protect a child's best interest."51 The court prohibited the CFSA from consenting to
administer the psychotropic medication, and held that a more formal and thorough
process conducted by the trial court should have determined whether medication
was in the child's best interest. 52 The D.C. court set forth the directive that a family
court "cannot exercise its discretion as parens patriae to intervene and overrule a
parent's prerogative unless it finds by clear and convincing evidence that doing so
would be in the best interests of the child."53 As no such hearing was held, the
decision to override the parent's objection to the psychotropic medication was
reversed and the parent's wishes were honored. 54
Providing consent to medicate their children with psychotropic medications
has great significance to parents. 55 The ability to consent to psychotropic
medications should be viewed as far more invasive and compelling than consenting
to general medical care. 56 When children are removed from their parents for abuse
or neglect and placed in the care of a social services agency, the social services
agency commonly seek a generalized consent for basic medical treatment. 57
However, authorizing consent for potent psychotropic medication for children is
quite different. 58
49. Id. at 566 (explaining that because psychotropic medication is not ordinary medical care,
decisions regarding a neglected child's psychotropic medication were presumptively within the scope of
residual parental rights).
50. [d. at 566-67.
51. Id. at 566 (holding that the CFSA lacked statutory authorization to consent).
52. Id. at 569 ("While the Family Court has the authority to overrule a natural parent's prerogative
regarding a neglected child's psychotropic medication, this discretion must be exercised, where
appropriate, after a careful consideration of all the relevant factors. And from the limited record before
us here, we cannot say whether the Family Court properly exercised its discretion in this case.").
53. In re G.K., 993 A.2d at 570.
54. Id.
55. See SOLCHANY, supra note 46, at 18 (noting that biological parents may disagree with foster
parents as to whether or not a child should be medicated, and that having the decision made by someone
who knows the child's specific needs is critical).
56. See id. at 4 (explaining that while psychotropic medications can be beneficial, misdiagnoses or
incorrect medications can "derail" or "sabotage" children's mental healing).
57. See LOURDES M. ROSADO, JUVENILE LAW CTR., CONSENT TO TREATMENT AND
CONFIDENTIALITY PROVISIONS AFFECTING MINORS IN PENNSYLVANIA 11-12 (2006) (explaining the
regulations surrounding the ability of various child welfare services in Pennsylvania to consent to
medical treatment for minors in their custody); see also SOLCHANY, supra note 46, at 18 (stating that in
some states, it is "the state or children's administration, the foster parent caring for the child, the court,
or state designated panels or overseers" that have the authority to consent to medication for children in
foster care. In other settings such as group homes, residential treatment centers, or inpatient psychiatric
institutions, physicians or staff may have consent to treat, which may include consent to administer
medications).
58. See Michael W. Naylor et aI., Psychotropic Medication Management for Youth in State Care:
Consent, Oversight, and Policy Considerations, 86 CHILD WELFARE 175, 179 (2007) ("The use of
psychotropic medications by children in state care presents unique challenges, particularly regarding
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In In Re Martin F.,59 an antipsychotic drug had been prescribed to a threeyear-old child over the objection of her mother.60 The Family Court in New York
explained that the consent to medicate required additional consent to be obtained,
separate from the more generalized consent usually obtained from parents when a
child enters protective custody.6! This acknowledgment that medicating children is
different and far more significant than consent for general medical care is to be
applauded.
The parent who has his child removed due to allegations of abuse or neglect
often feels overwhelmed. 62 In Martin F., the Department of Ruman Services
("DRS") that removed the three-year-old child routinely consulted parents, who
were given an opportunity to consent to treatment. 63 But if the parents did not
consent, their objections were simply overridden. 64 DRS's erroneous practice is
more evidence of the vulnerability of parents interacting with the foster care
system. 65 In its decision, the court relied on the notion that prescribing psychotropic
drugs is different than prescribing other medications, necessitating a higher level of
judicial scrutiny.66 The court held that the decision to administer Depakote was
unwarranted because it lacked an administrative review procedure or court
review. 67
Furthermore, the court distinguished "uncontroversial, immediate, and

issues of consent for and the oversight of psychotropic medications.").
59. 820 N.Y.S.2d 759 (N.Y. Fam. Ct. 2006).
60. Id. at 760-61. (explaining that after a child was placed in foster care based on her mother's
neglect, the Department of Human Services sought consent to administer Depakote sprinkles over the
objections of the child's mother).
61. Id. at 762-63 ("Thus, merely on the face of the state statute and its supporting regulations, it
might appear that the Commissioner of Human Services can simply determine what prescription
medicines shall be given to each and every child in foster care, without consulting with parents, but after
consulting with appropriate professionals. Such a simple process, however, does not recognize, or take
into consideration, the constitutional rights (I) of parents to make typical parental/family decisions for
their children and (2) of children to be protected from unwarranted state intrusion into their mental and
physical well-being.").
62. See. e.g., Kris Betts & Matt Olsen, Father of Foster Child Who Died Speaks to KVUE (Aug. I,
2013, 9:51
PM),
http://www.kvue.comlnews/Father-of-murdered-foster-child-speaks-to-KVUE218037541.html (describing a father's concerns about the treatment of his daughter in the foster system
and his reaction to discovering how his child died in foster care); see also MARION CNTY. CHILD. SERV.,
Frequently Asked Questions, http://www.marionkids.comlfaqs.html(last visited Oct. 27, 2013) ("Parents
who abuse or neglect their child are often under stress, pressure or in the midst of a crisis. Some parents
were abused themselves as children. Often families are overwhelmed and cannot cope with personal,
financial or marital problems.").
63. 820 N.Y.S.2d at 766.
64. Id. at 763.
65. Sandra Stukes Chipungu et aI., Meeting the Challenges of Contemporary Foster Care, 14
CHILD., FAM., AND FOSTER CARE 75, 78 (2004) ("Families who come to the attention of the child
welfare system are vulnerable families with complex needs.").
66. In re Martin F., 820 N.Y.S.2d at 773 (noting that the due process and fundamental liberty
interests of both parent and child were ignored in this case); see also Santosky v. Kramer, 455 U.S. 745,
747-48 (1982) (explaining the due process rights of parents who have neglected their children).
67. In re Martin F., 820 N.Y.S.2d at 768 (noting that because of the lack of an administrative
review process, the decision to administer the medication was made without deciding the merits of the
mother's objections).
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necessary care to foster children" from "potentially damaging mental health drugs.
. . ."68 The former is non-intrusive while the latter may not work and can be
objectionable to reasonable parents. 69 A parent's wishes may be usurped when there
is sufficient medical evidence to invoke the state's parens patriae authority, and if
the child's welfare will be served by the disputed treatmentJo The court recognized
the compelling state interest in utilizing its police power only where the patient
presents a danger to himself or others, engages in dangerous conduct while
institutionalized, or if the patient lacks the capacity to consent to take the drug. 71
The Family Court held that the DHS violated the due process rights of parents
because the DHS gave them no real rights-only the opportunity to consent. 72 The
court announced that the proper standard to be applied under the states' parens
patriae power to override a child's mental health medication determination over
parental objection was as follows:
[I]f the parent of a chi Id in foster care opposes the administration of
mental health medicine it cannot lawfully be prescribed unless the
court determines, after a hearing de novo with counsel, whether the
proposed treatment by medication is narrowly tailored to give the
substantive effect to the child patient's liberty interest, "taking into
consideration all relevant circumstances, including the child patient's
best interest, the benefits to be gained from the treatment, the
adverse side effects associated with the treatment, and any less
intrusive alternative treatments."73
Because the mother's refusal to consent should have been honored, the court
found that the case did not support the application of the parens patriae power to
override the mother's reasonable objection to Depakote Sprinkles being given to
her daughter. 74
Subsequent to a child being placed in foster care, a social service agency
generally seeks consent from the parent prior to administering psychotropic
medication to the child. 75 The details of this process are spelled out in the case of In

68. Id.
69. Id.; see also Rivers, 67 N.Y.2d at 497-99 (explaining that forcible medication to adults in
psychiatric hospitals as not always allowed).
70. In re Marlin F, 820 N.Y.S.2d at 770; see also Maller a/Cabrera, 552 A.2d 1114, 1118 (Pa.
Super. Ct. 1989) ("Accordingly, in cases where harm to the physical or mental health of the child is
demonstrated, these legitimate state interests may override the parents' qualified right to control the
upbringing of their children.").
71. In re Martin F., 820 N.Y.S.2d at 771; see also Rivers, 67 N.Y.2d at 498-99 (addressing an
adult's due process rights to oppose medication, thus requiring ajudicial determination).
72. In re Marlin F, 820 N.Y.S.2d at 771-72; but see In re A.S., 205 141 Cal. Rptr. 3d 255, 264
(20 12) (holding that a two-day requirement for a parent to file opposition to medication was reasonable).
73. In re Marlin F, 820 N.Y.S.2d at 772 (emphasis omitted) (quoting Rivers, 67 N.Y.2d at 497-98).
74. Id. at 773.
75. See Naylor, supra note 58, at 182 (stating that the most common method for welfare agencies to
obtain consent to provide psychotropic medications to youth in state custody is for legal guardians or
parents to give consent).
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re Lyle A.16 The court was critical of the DRS's method of obtaining the mother's
consent because the social services caseworker, rather than the prescribing
psychiatrist, spoke to the mother seeking her consent. 77 In addition, the court
faulted the caseworker for failing to provide the mother with information on
reasonably foreseeable risks and benefits, and alternative medications if the first
drug failed.1 8 The court held that an objecting parent should be permitted to consult
with an attorney just as an adult mentally ill patient held in a mental health facility
has a right to counseJ.79 Furthermore, the court was critical of the DRS's failure to
properly handle parental requests for changes in treatment, including requests to
withdraw parental consent. 80 The court emphasized the fundamental point that a
parent has the right to make medication determinations, even when their child is in
foster care. 81 The burden is placed on the DRS to demonstrate that the parent was
provided with the necessary information, given an opportunity to meet with the
prescribing physician, and an attorney to review the consent form with sufficient
time for the process to unfold in each case.82
When the state and parent agree that a child should be medicated, but the child
voices disagreement, what, if any, legal obligation should the court possess in
intervening to address the conflict? The traditional view that a parent possesses the
legal authority to consent to medical treatment for the minor child should be
questioned in light of the serious and dangerous consequences of prescribing
psychotropic medication to children. 83 The court should put in place a legal avenue
to address the grievance of a mentally ill child disputing the treatment plan agreed
upon by parent and psychiatrist. 84 The grievance process usually administered by an
independent judicial officer for mentally ill adults who dispute the medication
treatment plan should be extended to both minors and their parents.85
76. 830 N.Y.S.2d 486 (N.Y. Fam. Ct. 2006) (addressing the process of obtaining parental consent
and responding to a parental request to withdraw consent).
77. Id. at 490.
78. Id. at 490-92 (discussing the failure of the caseworker to meet the requirements that would
permit the parent to make an informed decision).
79. Id. at 494.
80. Id. at 487,494.
81. Id. at 495; see also In re Marlin F., 820 N.Y.S.2d at 769 ("The fundamental liberty interest of
natural parents in the care, custody and management of their child does not evaporate simply because
they have not been model parents or have lost temporary custody of their child to the State." (quoting
Santosky v. Kramer, 455 U.S. 745, 753 (1982)) (internal quotation marks omitted)).
82. In re Lyle A., 830 N.Y.S.2d, at 496.
83. See Rivers. 67 N.Y.2d at 497-98 (stating that the parent ofa child in foster care can legally deny
consent to administer psychotropic drugs to a child unless a court rules otherwise); see also SOLCHANY,
supra note 46, at 4 ("Medications can help children and teens in foster care, but they can also further
impair them, derail them, and sabotage them.").
84. See Hawkins, supra note 25, at 2077 ("[T]he Court has extended to minors the fundamental
rights of privacy and bodily integrity in the contraception and abortion contexts. In keeping with this
trend of affording children greater protection under the Constitution, a competent minor's right to make
certain medical decisions for herself should receive protection in most instances as well. If a minor has
the right to choose to undergo such an invasive procedure as an abortion, then certainly she should have
the right to refuse or accept other forms of medical treatment on her own behalf." (footnotes omitted)).
85. Id. at 2093 ("Given the recent judicial trend towards affording children greater protection under
the Constitution, a minor's right to make medical decisions for herself should receive full protection,
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B. Let Their Voices Ring: The Mature Child Who Opposes Psychotropic
Medication

There are occasions when a minor may refuse to consent to the administering
of psychotropic medication for the treatment of a mental illness. 86 Focusing on
situations when a minor is hospitalized in a psychiatric facility, a treating
psychiatrist may be confronted with a situation where a minor refuses to comply
with the medication regimen. 8? Should the psychiatrist seek parental approval, court
authorization, or honor a minor's refusal to consent? This fundamental question
turns on the issue of the rights of mentally ill children to control their mental health
treatment plan and the authority of others to override such a medication refusa1. 88
The decision to admit a child to a psychiatric hospital is often solely in the
hands of the parent. 89 In Parham v. J.R.,90 the United States Supreme Court
acknowledged that parents have a traditional interest in and responsibility for the
upbringing of their child, and therefore they retain a substantial role in the decision
on commitment, absent a finding of neglect or abuse. 91 The Supreme Court

and a minor should enjoy standing in contested medical treatment cases to protect her rights of infonned
consent, bodily integrity and self-detennination, and privacy." (citation omitted».
86. See, e.g., In re E.G., 549 N.E.2d 322,325 (III. 1989) (holding that a minor who the court has
determined to possess a requisite degree of maturity has limited rights to refuse life-sustaining medical
treatment); see also Rhonda Gay Hartman, Coming of Age: Devising Legislation for Adolescent Medical
Decision Making, 28 AM. J. L. & MED. 409, 420 (2002) ("Affording adolescents legal autonomy for
mental health treatment has occupied recent state legislative activity, resulting in varying requirements
and policy goals that are aimed at encouraging adolescent access to treatment. States that recognize a
minor's legal consent for mental health treatment usually place the onus for treatment determination on
the minor, as illustrated by Pennsylvania's provision that a minor who is fourteen years or older may
consent to examination and treatment if the minor 'believes that he is in need of treatment and
substantially understands the nature of voluntary treatment.'" (footnote omitted».
87. Some states allow children to refuse treatment, unless the treatment is court ordered. See, e.g.,
STATE OF WISCONSIN, DEP'T OF HEALTH SERV., Rights of Minors in Inpatient Community Mental
Health Facilities, http://www.dhs.wisconsin.gov/publications/p2/p20470a.pdf (last visited Oct. 27,
2013)(describing the right of minors fourteen years of age or older, who are admitted to inpatient mental
health facilities in the state of Wisconsin, to refuse treatment unless treatment is court ordered).
88. See HEATHER BOONSTRA ET AL., THE GUTTMACHER REPORT ON PUBLIC POLICY, MINORS AND
THE RIGHT TO CONSENT TO HEALTH CARE 4 (2000) ("On the one hand, it seems eminently reasonable
that parents should have the right and responsibility to make health care decisions for their minor child.
On the other hand, it may be more important for a young person to have access to confidential medical
services than it is to require that parents be informed of their child's condition .... Recognizing this
reality, many states explicitly authorize a minor to make decisions about their own medical care, but
balancing the rights of parents and the rights of minors remains a topic of debate."); cf Michael Leonard
Goff Jr., Protecting Our Mentally Ill: A Critique of the Role of Indiana State Courts in Protecting
Involuntarily Committed Mental Patients' Right to Refuse Medication, 76 IND. L.J. 983, 984 (2001)
("Indiana courts should recognize that a patient's fundamental rights are not contingent upon their
commission status and should be afforded full protection by applying strict judicial scrutiny to unwanted
treatment decisions.").
89. See, e.g., ILLINOIS CHILDREN'S MENTAL HEALTH PARTNERSHIP, RESIDENTIAL TREATMENT FOR
YOUTH WITH MENTAL HEALTH NEEDS: A GUIDE FOR PARENTS AND GUARDIANS 5 (Jean Davidson
Meister ed.) ("The decision to place a child in a residential facility is one of the most difficult and most
important choices that you can make for your child.").
90. 442 U.S. 584 (1979).
91. Id. at 604.
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recognized, however, that a child does have a substantial liberty interest in not
being confined unnecessarily for medical treatment,92 in part because such
commitment sometimes produces adverse social consequences for the child. 93 The
Court also recognized that the state is not without constitutional control over
parental discretion in dealing with children when their mental health is
jeopardized. 94
In our legal system, parents are the primary decision-makers for their children,
even over their child's objections, when it comes to medical procedures. 95 Children
are not viewed as capable of making sound judgments for certain care or
treatment. 96 However, there is a significant difference between a minor medical
procedure, like a tonsillectomy or appendectomy and a more significant procedure,
like obtaining an abortion or refusing psychotropic medication in a psychiatric
hospita1. 97 Recognizing this difference, the Court in Parham held that "the risk of
error inherent in a parental decision to have a child institutionalized for mental
health care is sufficiently great [to require an inquiry] by a 'neutral fact-finder' to
[ensure] the statutory requirements for admission are satisfied.''98
Next consider the situation where a child is no longer living in the care of a
parent but instead is placed in the custody of a social service agency. In the absence
of a parent's decision-making power over this child, the court system has a
responsibility to consider the voice of a mature child to speak on the issue of
receiving or refusing psychotropic medication. 99 This child should be front and
center in the decision-making process. IOO Of course, when all parties are in

92. Id. at 600.
93. Id.; see also Addington v. Texas, 441 U.S. 418, 425-26 (1979) ("Moreover, it is indisputable
that involuntary commitment to a mental hospital after a finding of probable dangerousness to self or
others can engender adverse social consequences to the individuaL"); cf Application of Gault, 387 U.S.
I, 23-24 ( 1967) (discussing the social stigma of labeling a juvenile as a delinquent).
94. Parham, 442 U.S. at 603 (additionally noting that a child not receiving proper medical treatment
and behaving abnormally in public may be ostracized or harmed, and that the child thus has a
protectable interest in not being labeled erroneously).
95. See id. at 603 ("Most children ... are not able to make sound judgments concerning ... their
need for medical care or treatment. Parents can and must make those judgments.").
96. Id.
97. See, e.g., Danforth, 428 U.S. at 75 (declaring a state statute that enabled parents to veto a minor
child's decision to have an abortion unconstitutional).
98. Parham, 442 U.S. at 606.
99. See, e.g., TENNESSEE DEP'T OF CHILDREN'S SERVICES, CLIENT'S RIGHTS HANDBOOK 8 (2012),
available at http://tennessee.gov/youthlpdfs/clientsrights.pdf (stating that Tennessee allows mature
fourteen-year-olds who are in the custody of the Department of Children's Services ("DCS") to refuse
treatment if it is determined that the child is mature enough to make such a decision; the decision by a
mature fourteen-year-old to refuse medical treatment or tests can only be overridden by judicial
intervention, which can only be sought after DCS consults with the prescribing healthcare provider and
it is determined that the treatment is in the best interests of the child and will protect the child from
harm).
100. See, e.g., In re E.G., 549 N.E.2d at 327-28 (discussing the mature minor doctrine and stating that
"[i]f the evidence is clear and convincing that the minor is mature enough to appreciate the
consequences of her actions, and that the minor is mature enough to exercise the judgment of an adult,
then the mature minor doctrine affords her the common law right to consent to or refuse medical
treatment").
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agreement as to the proper course of treatment, there is no compelling need for
judicial review. However, when the parent, social service agency, or child dissent,
objective third-party review is necessary. Children must be entitled to more
protections than adults,IOI necessitating third-party scrutiny and oversight, likely by
a judicial or administrative review. 102
Finally, a state's interest in administering psychotropic medication has been
seen as legitimate and important in certain situations, even over the consent of the
individual being medicated: 03 Specifically, courts have ruled that an individual
may be forcibly medicated if that person is a prison inmate with a serious mental
illness: 04 Even then, the treatment must be found to be in the inmate's medical
interest,105 and the inmate must found to be dangerous to himself or others.106
Similarly, in Riggins v. Nevada,107 the Supreme Court addressed the rights of
inmates to object to the administering of anti-psychotic drugs. lOS The Court in
Riggins set further limits on the forced medication of prison inmates, specifically
that the state must determine if there are less intrusive alternatives and determine
that the medication was medically appropriate and necessary for the inmate's safety
or the safety of others. 109
The Supreme Court later addressed the use of psychotropic
medication forcibly administered solely in order to render a
defendant competent to stand trial. I10 In Sell v. United States, III the
Court permitted the government to involuntarily administer antipsychotic drugs to mentally ill defendants if the treatment is
medically appropriate, substantially unlikely to have side effects, and
if the state explores less intrusive alternatives-and, even then, only
to ensure that the defendant has a fair trial. I12 This was a landmark
decision, for it marked the first time the Court held that a defendant
could be medicated, not due to dangerous behavior, but rather to
address the need to bring the defendant to trial. The Court found an

101. See Parham, 442 U.S. at 627 (noting that children are entitled to more protection than adults and
are, on average, confined for longer periods than adults).
102. See, e.g., Washington v. Harper, 494 U.S. 210, 233 (1990) (finding that administrative review
by medical decision-makers is an appropriate safeguard against a violation of a patient's due process
rights when they are medicated against their will).
103. See, e.g., id. at 236 (holding that the state interest in providing antipsychotic drugs outweighed
the inmate's liberty interest in refusing medical care).
104. See, e.g., id. (holding that the forced administration of antipsychotic drugs to prisoners is
permissible under the Constitution).
105. See, e.g., id. at 225 (stating that prison administrators have a duty to provide for prisoners'
medical interests).
106. See, e.g., id. at 236 (holding forced administration of antipsychotic drugs to inmates is
constitutional because it reduces the dangers that inmates present to themselves and others).
107. 504 U.S. 127 (1992).
108. Id. at 133.
109. Id. at 135.
110. See Sell v. United States, 539 U.S. 166, 169 (2003) (holding it constitutional to administer
antipsychotic drugs to a mentally ill criminal defendant to render him competent to stand trial).
111. Id.
112. Id. at 180-81.
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important governmental interest in bringing to trial a competent
individual accused of a serious crime.lI3
However, extending this right of the state from forcibly medicating a prison
inmate to forcibly medicating a child who has committed no crime and merely
diagnosed with a mental illness is quite a leap.114 The governmental interests in a
fair trial, preserving evidence, and avoiding memory loss of key witnesses are not
central to the decision to forcibly medicate a child who has committed no crime. lIS
In situations involving the refusal to consent to psychotropic medication, even
an adult's decision is not absolute." 6 In Maryland, for example, an involuntarily
committed, dangerous, mentally ill person may be forced to receive psychotropic
medication through an oversight clinical review panel and ultimately an
administrative hearing. I 17 Maryland law provides for a minor at age sixteen to have
the same capacity as an adult to consent to treatment of a mental health or
emotional disorder. I IS However, such capacity does not exist when a parent or
guardian of the minor has given consent. I 19
Courts have laid out the criteria for the forcible medication of the mentally ill,
confined patient. 120 In Maryland, the state's highest court articulated that standard
as requiring a finding that the patient was a danger to himself or others while
confined at the mental health facility. 121 The Kelly court restricted forcible
medication to situations where a mentally ill patient confined to a state institution
poses a danger to himself or others in the context of his confinement within the
state institution rather than, if released, to the general community.122
113. Id. at 179 (finding that the government has a substantial interest in timely prosecution to avoid
lost evidence and fading memories due to a delay in bringing the defendant to trial).
114. See. e.g., Superintendent of Belchertown State Sch. v. Saikewicz, 370 N.E.2d 417, 425 (Mass.
1979) (stating that the right for a state to force a minor to receive medical treatment serves four
governmental interests: "( I) the preservation of life; (2) the protection of the interests of innocent third
parties; (3) the prevention of suicide; and (4) maintaining the ethical integrity of the medical
profession").
115. Id.
116. See, e.g., MD. CODE ANN., HEALTH-GEN. § 1O-708(b) (West 2013) (stating that a doctor may
administer medication in an emergent situation where the patient presents a danger to the life and safety
of himself or others as well as in a non-emergent situation where the patient is involuntarily committed
and the medication is approved by a panel).
117. Id.
118. MD. CODE ANN., HEALTH-GEN. § 20-104 (West 2013).
119. Id.
120. See generally Jurasek v. Utah State Hosp., 158 F.3d 506, 511 (10th Cir. 1998) ("Accordingly,
the Due Process Clause allows a state hospital to forcibly medicate a mentally ill patient who has been
found incompetent to make medical decisions if the patient is dangerous to himself or others and the
treatment is in the patient's medical interests."); Steinkruger v. Miller, 612 N.W.2d 591,600 (S.D. 2000)
(holding that South Dakota's scheme for forcibly medicating mentally ill patients comports with the Due
Process Clause of the Fourteenth Amendment); Katz, 495 N.E.2d at 498 (holding that forcibly
administering medication is constitutional after the court balances the individual's liberty interest
"against the State's asserted compelling need on the facts of each case").
121. Dep't of Health & Mental Hygiene v. Kelly, 918 A.2d 470, 492 (Md. 2007).
122. Id. at 492; see also Youngberg v. Romeo, 457 U.S. 307, 324 (1982) (holding a mentally ill
person confined to a state institution possesses a liberty interest protected by the due process clause of
the Fourteenth Amendment to safe conditions, freedom from unreasonable bodily restraints, and
minimally adequate or reasonable training).
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This standard, of proving that the patient must be at substantial risk of
continued hospitalization due to remaining mentally ill, in the context of the
institutionalization, represents a higher threshold to require forcible medication
than previous cases permitted. '23 The Kelly court placed a reasonable limitation on
the hospital's authority to forcibly medicate a patient who objects, properly
reigning in such power.124 What follows from the Maryland forced medication
cases should be the recognition that we must respect and honor the wishes of the
mentally ill patient and her freedom from intrusive psychotropic medication
without the necessary judicial oversight. '25

c. Who Consents: Ethical Issues When Prescribing Psychotropic Medication to
Children
What should we as a society do when the decision to medicate mentally ill
children arises? When the need to medicate arises, social service agencies and
courts seek to obtain informed consent from all the parents. 126 Physicians often turn
to parents, guardians, or social service agencies to provide consent for minors.'27 As
a last resort, some states provide an independent physician to review or judicial
authorization to provide the necessary consent. 128 However, where is the
recognition that mature, competent children should be consulted on the matter of
psychotropic medication?'29 At age sixteen, a minor may very well be capable of
authorizing consent or refusing to consent to such medication administration. no
There are two distinct and separate decisions to be made with respect to

123. See Kelly, 918 A.2d at 489 (quoting the Supreme Court's standard in Harper regarding the
permissibility of forcible medication of psychotic drugs on a mentally ill inmate); see also Williams v.
Wilzack, 573 A.2d 809,821 (Md. 1990) (recognizing an inmate has a significant constitutional liberty
interest to be free from arbitrary administration of anti-psychotic drugs).
124. Kelly, 918 A.2d at 492 (holding that Maryland Department of Health and Human Hygiene was
not authorized to forcibly medicate the patient, who was not involuntarily confined to medical facility
after he was found not competent to stand trial, without a finding that the patient was a danger to himself
or others while confined in the medical facility).
125. Id.
126. See, e.g., S.D. CODIFIED LAWS § 27 A-15-46 (2013) (requiring oral and written informed consent
from a parent or guardian when a minor under sixteen is prescribed psychotropic medication); § 27A-1547 (requiring oral and written informed consent from a parent or guardian and from a minor who is age
sixteen or older when the minor is prescribed psychotropic medication).
127. See Hodgson, 497 U.S. at 483 ("The common law historically has given recognition to the right
of parents, not merely to be notified of their children's actions, but to speak and act on their behalf.").
128. See Harper, 494 U.S. at 233 (holding administrative review by medical decision-makers is
sufficient to satisfy the due process rights of a patient who was forcibly medicated).
129. See Jay C. Costello, Why Have Hearings for Kids if You Are Not Going to Listen?: A
Therapeutic Jurisprudence Approach to Mental Disability Proceedings for Minors, 71 U. ON. L. REV.
19,27 (2002) (analogizing a competent minor's right to an abortion with a competent minor's right to
refuse or consent to psychotropic medication).
130. See Supplemental Security Income: Determining Disability for a Child Under Age 18, 58 Fed.
Reg. 47532-01 (Sept. 9, 1993) (to be codified at 20 C.F.R. § 416) (acknowledging "the functional
abilities, skills, and behaviors that are age-appropriate for 16-to-18-year-olds are those that are also ageappropriate for 18-year-olds"); Laurence Steinberg, A Social Neuroscience Perspective on Adolescent
Risk-Taking, 28 DEVELOPMENTAL REV. J. 78, 80 (2008) (stating "[t]he logical reasoning and basic
information-processing abilities of 16-year-olds are comparable to those of adults").
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psychotropic medication for children.13l First, should doctors prescribe
psychotropic medication when both the parent and child agree on accepting the
medication?132 Next, what determines the course of action when either the parent or
minor rejects the medication being prescribed?133 When the parent rejects, but the
child consents, should physicians administer the medication or seek judicial
approval? For the physician's protection, judicial approval is the appropriate course
of action. \34 What, however, should physicians do when the parent consents and the
juvenile refuses? Add to this question that the minor is sixteen years of age and
viewed as confident to consent. 135 Should the physician ignore the wishes of the
child and singly honor the parent's wishes when they conflict with the desires of
the child? Physicians should again seek judicial approva1. 136 At such a proceeding,
the wishes of the child should be considered in evaluating the issue of consent.137
There ought to be prescriptions that at age sixteen, the child's wishes should
override the parents' wishes.138 Only if a court determines that the minor is not
capable of providing informed consent should the parent's wishes be permitted to
substitute for that of the minor child, at age sixteen and above. \39
There is a considerable variation in state laws that provide for the age of
consent for mental health treatment. 140 On one extreme, in California, the threshold
age where a minor may consent to mental health treatment is twelve years old. The
child's ability to authorize does not include consent to psychotropic drugs, at least
not without the consent of the minor's parent. 141 In Florida, a minor at age thirteen
131. See generally Stephen A. Talmadge, Who Should Determine What Is Bestlor Children in State
Custody Who Object to Psychotropic Medication?, 15 ANNALS HEALTH L. 183, 187 (2006)
("Psychotropic medications can be administered either voluntarily or involuntarily.").
132. See, e.g., S.D. CODIFIED LAWS § 27A-15-47 (2013) (allowing doctors to prescribe psychotropic
medications to minors who are age sixteen or older if both the minor and parent provide informed
consent).
133. See Susan O. Scheutzow, I HEALTH L. PRAC. GUIDE § 11:15 (West 2013) (stating judicial
intervention may be necessary when a parent and minor disagree about treatment).
134. !d.
135. See Andrew Newman, Adolescent Consent to Routine Medical and Surgical Treatment: A
Proposal to Simplify the Law o.fTeenage Medical Decision Making, 22 J. LEGAL MED. 501,531 (2001)
("In the absence of any scientific studies showing that a 16-year-old has less judgment than an 18-yearold (or older), the general consensus on a 16-year-old having sufficient competence should carry the
day").
136. See Scheutzow, supra note 133 (stating judicial intervention may be necessary when a parent
and minor disagree about treatment).
137. See People v. Medina, 705 P.2d 961,973 (Colo. 1985) (stating a judge must ask the patient his
views on the treatment at a judicial hearing).
138. See Newman, supra note 135, at 530-32 (arguing a bright line standard of giving sixteen year
olds autonomy in medical standards would alleviate the burden on the court to determine the maturity of
the minor).
139. See Grant H. Morris, "Let's Do the Time Warp Again": Assessing the Competence olCounsel in
Mental Health Conservatorship Proceedings, 46 SAN DIEGO L. REv. 283, 294 (2009) (stating a guardian
may give informed consent if an individual is determined to be incompetent).
140. See Hartman, supra note 86, at 420 (stating limitations on whether adolescents can consent to
mental health treatment varies considerably by state).
141. CAL. HEALTH & SAFETY CODE § 124260 (West 2013) (stating that consent of the twelve year
old is contingent on the attending professional assessment that the minor is mature enough to participate
intelligently in the mental health treatment).
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may receive mental health diagnostic and evaluative services; however,
psychotropic medication is exempt from such services. '42 In Alabama, a minor who
is fourteen years of age or older may provide consent to any legally authorized
medical or mental health services, including psychotropic medications. 143 Similarly,
Oregon authorizes a minor at age fourteen to obtain outpatient diagnosis or
treatment for a mental health disorder without parental knowledge or consent. 144
The District of Columbia has also recognized the ability of older adolescents
to consent to serious medical treatment. 145 While minors under the age of sixteen
may not consent to the administration of psychotropic medication in any event
absent emergency, minors who are sixteen years and older are, able to consent to
such treatments without parental approval in certain circumstances. '46 Such a
provision is a major step in acknowledging that a minor at age sixteen possesses the
capacity to consent to receiving a psychotropic medication for the treatment of his
or her own mental illness. 147 State legislatures are encouraged to extend this
protection to minors who have reached age sixteen by providing them with the
exclusive authority to refuse or consent to the administration of psychotropic
medication. 148
A minor's authority to seek voluntary admission into a psychiatric in-patient
facility for mental health services is occasionally stipulated in state legislation. For
example, a minor can seek said admission in Colorado at age fifteen,'49 and in
Maryland, at age sixteen.'5o These state legislatures, recognizing the maturity of
older adolescents, grant them autonomy to make the serious decision to be
voluntarily admitted into a psychiatric hospital.' 51 Other state legislatures should be
encouraged to acknowledge the maturity of sixteen-year-olds and place similar
decision-making authority in their hands. 152
In light of the overwhelming evidence regarding problems involved with
142. FLA. STAT. ANN. § 394.4784(1)-(2) (West 2013); see also CONN. GEN. STAT. ANN. § 19a-14c
(West 2013) (stating that a minor, at no minimum age, may receive mental health treatment, not
including dispensing medication).
143. ALA. CODE § 22-8-4 (West 2013); see also MICH. COMPo LAWS ANN. § 330.1707 (West 2013)
(penniting a minor at age fourteen to receive outpatient mental health treatment without the parent's
consent with the exception of psychotropic drugs).
144. OR. REV. STAT. ANN. § 109.675(1) (2007); but see id. § 109.675(2) ("However, the person
providing treatment shall have the parents of the minor involved before the end of treatment ... ").
145. D.C. CODE § 7-1231.14(c)(2)(a)-(c) (2001).
146. See id. (providing for situations where a minor would not have to rely upon parental consent for
such treatment).
147. See id. (recognizing a sixteen-year-old's ability to consent in receiving psychotropic medication
without parental consent in certain circumstances).
148. See id. (acknowledging sixteen as the appropriate age to give consent under particular
circumstances); Newman, supra note 135, at 508 (regarding the recommended age of consent, absent
parental agreement, for certain medical procedures: "[rJather than engaging in SUbjective analyses of
maturity factors, it would be simpler and more efficient to use a chronologie test, using age 16 as the
cutofl").
149. COLO. REv. STAT. ANN. § 27-65-103(2)(West 2010).
150. MD. CODE ANN., HEALTH-GEN. § 1O-609(a)(West 2009).
151. [d.; COLO. REV. STAT. ANN. § 27-65-103(2).
152. See Newman, supra note 135, at 508 (stating that age sixteen is a suitable cutoff in detennining
the right to consent to medical treatment with or without parental consent).
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medicating minors with psychotropic medication-including, but not limited to
concomitant use, prescribing these medications off-label and without FDA
approval-we must ask ourselves: who is monitoring such actions on the part of the
prescriber? There should be supervision prior to and during the treatment of
children who are prescribed psychotropic medication. 153 Psychiatric hospitals bear
some responsibility to provide the risks and alternatives to psychotropic medication
prior to administering such medication to their young patients. 154
Prior to prescribing psychotropic medications to minors, physicians should
provide both the child and the parent the purpose of psychotropic medications, side
effects, and alternative treatment options. 155 For children in foster care, the
explanation should also be given in person to a foster care caseworker or a
designated medication consultant. 156
In Maryland, for example, while a sixteen-year-old minor is permitted to seek
voluntary admission to an in-patient psychiatric facility regardless of his or her
parent or guardian's wishes,157 when said minor elects to refuse psychotropic
medication, the hospital may, oddly enough, tum to a parent or guardian to
authorize the psychotropic medication. 15s Of course, treating psychiatrists have the
option of using clinical review panels and administrative hearings to force a
psychiatric patient to be medicated involuntarily.159 A treating psychiatrist,
however, does not appear to be required to pursue this same forced medication
route for a minor that is mandated for an adult. 160 Treating psychiatrists should
consider following the same approach that is followed for adults when treating
minors. 161 The treating psychiatrist who relies on the consent of the minor's parents

153. Glenn S. Hirsch, Guide to Psychiatric Medications for Children and Adolescents, ABOUT OUR
KIDS.ORG,
http://www.aboutourkids.org/articles/guide_psychiatric_medications_children_adolescents
(last visited Oct. 24, 2013) ("Children should take these medications only under the careful supervision
of their physicians.").
154. See Harvey Dondershire, Legal Aspects of Hospital Psychiatry, STANFORD.EDU,
http://www.stanford.edulgroup/psylawseminar/lnpatient.htm (last visited Oct. 24, 2013) (enumerating a
list of questions to ask patients in order to procure adequate consent from a patient before administering
psychotropic drugs to avoid hospital liability).

155. Psychiatric Medication For Children and Adolescents Part I-How Medications Are Used,
AMERICAN
ACADEMY
OF
CHILD
&
ADOLESCENT
PSYCHIATRY,
(Nov.
2012),
http://www.aacap.org/AACAP/Families_and_YouthiFacts_for_Families/Facts_for_Families_PageslPsyc
hiatric_Medication_F or_ Children_And_Adolescents_Part_I_How_Medications_Are_Used_21 .aspx
(last visited Oct. 27, 2013).
156. See SOLCHANY, supra note 46, at 4.
157. See MD. CODE ANN., HEALTH-GEN. § 10-609(a) ("Application for voluntary admission of an
individual may be made under this section by the individual, if the individual is 16 years old or older.").
158. See MD. CODE ANN., HEALTH-GEN. § 20-104(a)(I)-(2) (West 2007) (stating that while sixteenyear-old persons have the capacity to consent to such treatment, they do not possess the capacity to
refuse treatment for which a parent or guardian has given consent).
159. MD. CODE ANN., HEALTH-GEN. § 10-708 (West 2009).
160. See id. (lacking indication of forced medication protocol for minors).
161. Ethics in Clerkships: Informed Consent, UNIVERSITY OF ILLINOIS AT CHICAGO COLLEGE OF
MEDICINE, http://www.uic.eduldepts/mcamlethicS/ic.htm (last visited Oct. 27, 2013) (recognizing that
the rights of parents regarding their children's medical treatment is not absolute and is sometimes
subject to the doctrine of the "maturing adolescent" which can override parental consent in some
situations).
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may be on thin ice when it comes to informed consent. 162 The two conflicting
regulations discussed above provide an example of the danger of not clarifying the
rules, leaving them incongruous: one provides for a minor who is sixteen years of
age to have the same capacity to consent to treatment for a mental disorder, while
the other does not include the capacity to refuse treatment when a parent has
consented. '63 However, the only legitimate mechanism to forcibly medicate an
involuntarily committed mentally ill individual is through forcible medication
protocol. l64 This creates an inherent problem when a parent consents to
psychotropic medication for their minor child between sixteen and eighteen years
of age but the minor refuses to consent to the medication. 165 Psychiatrists should
only resort to the forcibly medicating such patients through the forced medication
avenue because there is no clear protocol for this particular situation. '66 Anything
less would allow a parent to override the wishes of his or her minor child (sixteen
to eighteen years of age) under questionable legal authority.'67 Because the statute
provides that a sixteen-year-old has the ability to consent to treatment, this
individual should also be able to have the capacity to refuse such medication
without the threat of parental supersession. '68
It is recommended that minors, upon reaching age sixteen, should be permitted
to refuse to receive psychotropic medication. 169 The next step for the treating
psychiatrist who insists on forcibly medicating the minor patient should be to
obtain judicially sanctioned permission. 170 The legal process followed for adult
162. See id. (indicating that parental consent will not always qualify as "informed consent" in the
case of "maturing adolescents").
163. MD. CODE ANN., HEALTH-GEN. § 20-104(a)(1)-(2) (West 2007).
164. For an example of such a protocol, see, e.g., MD. CODE ANN., HEALTH-GEN. § 10-708 (West
2009) ("(b) Medication may not be administered to an individual who refuses the medication, except: (I)
In an emergency, on the order of a physician where the individual presents a danger to the life or safety
of the individual or others; or (2) In a nonemergency, when the individual is hospitalized involuntarily
or committed for treatment by order of a court and the medication is approved by a panel under the
provisions of this section.").
165. See MD. CODE ANN., HEALTH-GEN. § 20-104(a)(I)-(2) (stating that while sixteen year old
persons have the capacity to consent to such treatment, they do not possess the capacity to refuse
treatment for which a parent or guardian has given consent).
166. See Ethics in Clerkships: Informed Consent, supra note 161 (stating that parental rights are not
necessarily absolute regarding a minor's consent to medical treatment due to the "maturing adolescent"
theory).
167. See In re Roger s., 569 P.2d 1286, 1292 (1977) (supporting the conclusion that parental consent
does not always equate to legality by holding that a fourteen year old minor was entitled to his own due
process rights and his parents could not override them).
168. See Kathryn Hickey, Minors' Rights in Medical Decision Making, 9 laNA'S HEALTHCARE L,
ETHICS, & REG., 100, 102 (2007), available at https://nursing.ceconnection.com/nuiovidfiles/00128488200707000-000 13.pdf. (explaining that a minor "deemed able to understand short and long-term
consequences is considered to be 'mature' and thus able to provide informed consent/refusal for medical
treatment").
169. See Newman, supra note 135, at 508 (stating that age sixteen is a suitable cutoff in determining
the right to consent to medical treatment absent parental consent); see also In re E.G., 549 N.E.2d at 378
(holding that a minor who was competent enough to consent to life-sustaining treatment, was also
competent enough to refuse that treatment).
170. See Ethics in Clerkships: Informed Consent, supra note 161 (supporting the conclusion that
parental consent may not be the best avenue to force medication upon "mature adolescents" because it is
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patients who refuse psychotropic medication should be extended to those mmor
patients aged sixteen and above. I7I
One must consider what the treating physician should do if one or more of the
key individuals-child, parent, or agency-disagree with the treatment plan being
proposed. 172 The American Medical Association's ("AMA") Code of Medical
Ethics states, in part:
The patient's right of self-decision can be effectively exercised only
if the patient possesses enough information to enable an informed
choice. The patient should make his or her own determination about
treatment. The physician's obligation is to present the medical facts
accurately to the patient or to the individual responsible for the
patient's care and to make recommendations for management in
accordance with good medical practice. '73
The AMA clearly articulates the requirement, in accordance with good
medical practice, of providing sufficient enough information to the patient so that
he or she can make an informed choice. '74 The AMA also acknowledges that the
physician's obligation is to the patient himself, "or the individual responsible for
the patient's care."175 The AMA should explicitly state its preferred approach for
providing information to the minor patient who is mature enough to understand the
risks and benefits of the treatment as well as to the parent of the patient. '76 In
recommending psychotropic medication to children, the mature child and parent
should be provided with information. 177 The assessment of when a minor is mature
enough to receive an explanation may vary, from eighteen to fourteen or sixteen, or
the AMA could simply leave it in the hands of a treating physician to make a caseby-case assessment as to the maturity level of each individual minor patient
individually. 178
It is proposed that a more consistent approach should be established, with age

sometimes not dispositive of a mature adolescent's consent).
171. Id.; see Newman, supra note 135, at 508 (stating that age sixteen is a suitable cutoff in
determining the right to consent to medical treatment absent parental consent).
172. See Hickey, supra note 168, at 101 ("Matters become much more complicated when [competent
minors and parents] disagree. Nursing administrators, who may be called upon to intervene, may need to
seek legal counsel to sort out the variety of interests involved in these circumstances.").
173. Opinion
8.08
Informed
Consent,
AM.
MED.
ASS'N,
http://www.amaassn.orgllamalpub/physician-resources/medical-ethics/code-medical-ethics/opinion808.page
(last
updated Nov. 2006).
174. Id.
175. Id.
176. See Hickey, supra note 168, at 103 ("The medical information of every individual is protected
by federal and state constitutions, statutes, regulations, and previous court decisions. However, the
ambiguous state of self-determination of adolescents presents challenges to confidentiality safeguards.").
177. Id.
178. See Opinion 8.08 - Informed Consent, supra note 173 ("Physicians should sensitively and
respectfully disclose all relevant medical information to patients. The quantity and specificity of this
information should be tailored to meet the preferences and needs of individual patients.").
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sixteen being the bright line cutoff for the age of consent. 179 Physicians should still
be able to make individual assessments as to how much information should be
provided to patients; as the AMA puts it, the "quantity and specificity of
medication information should be tailored to meet the preferences and needs of
individual patients."lso However, when it comes to the decision of receiving
psychotropic medication, a consistent and standardized rule requiring sixteen and
seventeen-year-old minors to consent and refuse medication should be imposed. lSI
When a sixteen year old refuses to consent to psychotropic medications, the
physician should institute the same formal administrative or judicial override
procedure that currently exists for adults who refuse psychotropic medication. ls2
This additional requirement would recognize the AMA mandate that a patient
should make his own decision about treatment while also appreciating the
significance of putting psychotropic medication into the bodies of our nation's
children. ls3
The doctrine of informed consent has long been recognized as a guiding
principle in medical treatrnent. IS4 The doctrine of informed consent imposes on a
physician the duty to explain the procedure to the patient and to warn of any
material risks or dangers inherent in the therapy prior to medical treatment: S5 This
enables the patient to make an intelligent and informed choice whether to undergo
the proposed treatment. IS6 The importance of obtaining informed consent must be
recognized for minors starting at the age of sixteen. ls7

D. Recommendations for Obtaining Informed Consent
Certain information should be provided to the child, parent or guardian prior
to obtaining informed consent to medicate a child with psychotropic medication.

179. See Newman, supra note 135, at 508 (stating that age sixteen is a suitable cutoff in detennining
the right to consent to medical treatment absent parental consent); see also Hickey, supra note 168, at
103 ("[T]he ambiguous state of self-determination of adolescents presents challenges to confidentiality
safeguards.").
180. Opinion 8.08 - Informed Consent, supra note 173.
181. See Newman, supra note 135, at 508 (supporting the conclusion that sixteen should be used as a
bright line rule in detennining a minor's capacity to consent without parental interference); see also In
re E.G., 549 N.E.2d at 378 (holding a minor who was competent enough to consent to life-sustaining
treatment was also competent enough to refuse that treatment).
182. See MD. CODE ANN., HEALTH-GEN. § 10-708 (detailing the procedures available to override a
patient's refusal of medication).
183. Opinion 8.08 - Informed Consent, supra note 173 ("The patient should make his or her own
determination about treatment."); see Solchany, supra note 46, at 14 (indicating that the impact of
psychotropic medication on children is more profound than it is on adults).
184. Sard v. Hardy, 379 A.2d 1014, 1019 (1977) (quoting Schloendorffv. Soc'y of New York Hosp.,
105 N.E. 92, 93 (1914) (Cardozo,
("Every human being of adult years and sound mind has a right to
determine what shall be done with his own body").
185. Id.
186. Id. at 1020.
187. See Newman, supra note 135, at 508 (stating that age sixteen is a suitable cutoff in detennining
the right to consent to medical treatment absent parental consent); see also Hickey, supra note 168, at
101 (indicating that discrepancies between the age of consent and "surrogate" decision making by
parents leads to problems for physicians which must be remedied by the law).

J.»
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Where applicable, this information should also be provided to the social service
agency that is responsible for the care and treatment of the child. 188 At a minimum,
the following information should be provided:
1.
2.

3.
4.
5.
6.
7.
8.
9.
10.
11.

12.
13.
14.
15.

The list of medications prescribed;
The behavior or symptoms to which the medication is intended to
modify;189
The dosage,190 time of administration (both the starting and the maximum
dose allowed),191 and frequency;
How possible side effects of the medication will be treated;192
The duration of the course of treatment for the administration of the
medication; 193
A description of the possible risks, side effects, interactions with other
medications or foods, and complications of the medication;194
Tests or procedures likely required as a result of the medication, before
enduring the regimen;195
Alternative treatments or medications;
The diagnosis or target symptoms for the medication;196
The benefits/intended outcomes of treatment; 197
The likely results of not taking the recommended medication;198
The right to withdraw voluntary consent for medication at any time;199
FDA status of the medication;20o
Diagnosis (DSM-5);20I
List of the child's non-psychotropic medications, including any nutritional

188. SOLCHANY, supra note 46, at 4.
189. N.J. ADMIN. CODE § 10: I 27-7.5(e)(I)(i) (2009).
190. Id. at (b)(3)(i).

191. See Psychotropic Medication Treatment Plan Review, CF-FSP 5279, FLA. DEPT. OF CHILDREN
& FAMILIES (Sept. 2010), available at www.dcf.state.f1.us/initiatives/GMWorkgroup/docsICFOPI7598.pdf (describing a protocol for a case manager to request a prescribing practitioner to obtain a
psychotropic medication treatment plan for the child).
192. N.J. ADMIN. CODE § \0: I 27-7.5(b)(3)(iv); OR. ADMIN. R. 413-070-0490 (2013).
193. MINN. R. 2960.0620 (2013).
194. NEV. REV. STAT. ANN. § 432B.4687(2)(a)(6) (West 2011).
195. See MINN. R. 2960.0620 (indicating that physicians need to inform patients of likely results and
side effects of the medication).
196. ARIZ. DEPT. OF HEALTH SERVS.,PSYCHOTROPIC MEDICATION: PRESCRIBING AND MONITORING
§ 3.15 (2010), available at http://www.azdhs.gov/bhs/provider/sec3_15.pdf. The form is also attached in
Appendix A.
197. Id.
198. Id.
199. Id. (noting the right to withdraw consent subject to court order authorizing medication).
200. Id.
201. DSM-5 Development, AM. PSYCHIATRIC ASS'N, http://www.dsm5.org/aboutiPages/faq.aspx
(last visited Nov. 29, 2013) ("The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the
handbook used by health care professionals in the United States and much of the world as the
authoritative guide to the diagnosis of mental disorders . . . . DSM-5 is a manual for assessment and
diagnosis of mental disorders and does not include information or guidelines for treatment of any
disorder.").
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supplements;202
16. Explanation/reason for request to continue current medications, dosage
adjustment, or new medication;203
17. Allergies and likely adverse reactions;204
18. Access to a website with monitoring protocols, maximum dosage
guidelines, and approved medication list;205
19. Medication that was discontinued and the reasons for the discontinuation;206
20. Name and specialty of the licensed prescriber;207
21. Child's name, date of birth, and weight;208
22. Expiration date of the consent form, review date, duration of consent form
shall not exceed 90 days;209
23. Concomitant medication use;210
24. Requirement for second opinion in the following situations: medicating
minors under the age of six, when the medication prescribed is "off-label"
(when FDA protocol is not followed),211 when three or more psychotropic
medications are prescribed at the same time,212 the first time a child is
prescribed psychotropic medication,213 when a parent/guardian of a minor
aged sixteen or older disagrees with the decision of the child;214
25. Notice of rights of child, parent or guardian, social service agency and
treating psychiatrist if there is an objection to the use of the prescribed
medication or prescribed dosage.215
The steps taken upon a sixteen-year-old minor's refusal to consent should be
clearly spelled out in the consent form, and the prohibition on administering the

202. Psychotropic Medication Consent Request Form, CONN. DEP'T OF CHILDREN & FAMILIES,
http://www.ct.gov/dcf/cwp/view.asp?a=4518&q=386456 (last visited Oct. 27,2013).
203. Id.
204. Id.
205. See, e.g., Psychotropic Medication Information, CONN. DEP'T OF CHILDREN & FAMILIES,
http://www.ct.gov/dcf/cwp/view.asp?a=4518&q=386456 (last visited Oct. 27, 2013) (providing an
example of such a website).
206. 89 ILL. ADMIN. CODE § 325.30(i)(12) (2012).
207. § 325.30(i)(7).
208. § 325.30(i)( I).
209. ARIZ. DEPT. OF HEALTH SERVS., supra note 196.
210. See, e.g., Zito et aI., supra note I, at el57 (concluding that concomitant psychotropic medication
treatment is frequent for youth in foster care and lacks substantive evidence as to its effectiveness and
safety).
211. See SOLCHANY, supra note 46, at 17 ("Using medications 'off label' is legal and has proved to
benefit many individuals; however concerns have been raised about risks of widespread off-label use
and the understanding of off-label use by prescribers and patients").
212. See 89 ILL. ADMIN. CODE § 325 App. A (2013) (adding that a child six years of age or younger
being concomitantly prescribed three or more psychotropic medications "will trigger a closer review of a
patient's care and possible denial of psychotropic medication requests").
213. See SOLCHANY, supra note 46, at 28 ("Successful medication management includes regular
follow-ups. Especially when first started, medications often need to be adjusted for proper dosage or
better timing. ").
214. ARIZ. DEPT. OF HEALTH SERVS., supra note 196.
215. Id.
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prescribed medication over the objection of the minor, parent, or guardian without
court order should be clearly delineated.216 The burden of proceeding with
administering the medication on parent or guardian refusal should be with the party
or agency seeking to medicate the minor. 217 Prior to court authorization, no
psychotropic medication should be administered unless an emergency exists.218
Extending legal protection to a child at age sixteen and above is an important
step in restoring authority to mature minors.219 Such vulnerable children should be
given a seat at the decision-making table. 220 Foster children, who are often betrayed
by their parents and forgotten by the foster care system, require the same
protections but also additional oversight and monitoring to ensure their safety.221
II. AN INDICTMENT OF THE MENTAL HEALTH SYSTEM FOR CHILDREN:
OVERMEDICA TION AND PARTICULAR CONCERNS FOR FOSTER CHILDREN

A. Warning Sign

Children who are victims of abuse, neglect, or abandonment and placed in the
foster care system present unique challenges to the psychiatric community. Many
of these children have experienced traumatic events such as sexual abuse, physical
and emotional abuse, and parental abandonment. 222 As a result, these children often
experience significant emotional harm and cross paths with mental health
professionals. 223 These damaged children are often prescribed psychotropic
medication to address their mental disorders.224
Recent studies have reported that psychotropic medications are being
prescribed for foster children at a higher rate than non-foster children.225 The U.S.
Government Accountability Office ("GAO") conducted an exhaustive survey
comparing the rate of psychotropic medication for foster and non-foster children in

216. Id.
217. See id. (explaining that prior to medication being administered involuntarily, a child sixteen or
older or a parent or guardian has the right to request an administrative hearing).
218. See MD. CODE ANN., HEALTH-GEN. § 10-708 (West 2009) ("(b) Medication may not be
administered to an individual who refuses the medication, except: (I) In an emergency, on the order of a
physician where the individual presents a danger to the life or safety of the individual or others; or (2) In
a nonemergency, when the individual is hospitalized involuntarily or committed for treatment by order
ofa court and the medication is approved by a panel under the provisions of this section.").
219. ARIZ. DEPT. OF HEALTH SERVS., supra note 196 (noting that a child sixteen years of age or older
may refuse to consent to medication).

220. Id.
221. SOLCHANY. supra note 46, at 3.
222. U.S. GOV'T ACCOUNTABILITY OFFICE, GAO-12-201, FOSTER CHILDREN: HHS GUIDANCE
COULD HELP STATES IMPROVE OVERSIGHT OF PSYCHOTROPIC PRESCRIPTIONS I (2011) [hereinafter
U.S. GAO, FOSTER CHILDREN] ("Children placed in foster care are among our nation's most vulnerable
populations. Often having been removed from abusive or neglectful homes, they tend to have more
numerous and serious medical and mental health conditions than do other children." (footnote omitted».
223. Id. at 5.
224. Id. at I.
225. See id. at 7 ("Foster children in each of the five selected states were prescribed psychotropic
drugs at higher rates than were non foster children in Medicaid during 2008." (footnote omitted».
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five states. 226 The ratio of foster children on psychotropic medication was between
2.7 and 4.5 times the rate for children not in foster care on Medicaid in 2008.227 In
addition, the GAO study revealed that on average 28.8% of foster children received
prescription medication, as compared to 7.64% of non-foster children in Medicaid
2008.228 This study also indicated increased likelihood of foster care children to
have five or more psychotropic prescriptions than children outside of the system. 229
This significant and alarming trend creates potential health risks.230
Several plausible explanations have been suggested for the high rate of foster
children on psychotropic medications, ranging from greater exposure to trauma,231
frequent changes in foster placement,232 and varying state oversight policies.233
However, the significant and lopsided medication excesses of foster children may
have other explanations, such as more opportunities of mental health professionals
to come in contact with foster children, the desire to control and discipline foster
children, and the ready access of physicians willing to prescribe psychotropic
medication as a quick fix to a complicated and challenging problem.
In 2012, the GAO issued a Children's Mental Health report that looked closely
at foster children. 234 In the report, there is an acknowledgment that children
removed from their parents due to parental violence, substance abuse, severe
depression, or incarceration suffer significant traumatic stress.235 Such trauma
"significantly increases the risk of mental health problems, difficulties with social
relationships and behavior, physical illness, and poor school performance."236
Unfortunately, such traumatic stress symptoms are often identical to the symptoms
that indicate other mental health conditions, which may lead to misdiagnosis and
inappropriate treatments. 237 Additionally, a state's child welfare agency is
responsible for determining the child's living arrangement and often places the
child in foster care, a group home, or a residential treatment center depending on
the needs of the child.238 As such, foster children often experience frequent changes

226. See id. at 3 (explaining that data was reviewed from Florida, Massachusetts, Michigan, Oregon,
and Texas).
227. Id. at 8 (as displayed in Appendix XVII, at 101-05).
228. U.S. GAO, FOSTER CHILDREN, supra note 222, at 101-05.
229. Id. at 14 (reporting that "the rate of children prescribed five or more psychotropic drugs
concomitantly ranged from 0.11 to 1.33 percent among foster children compared with a lower 0.0 I to
0.07 percent rate among nonfoster children").
230. Id. (referring to the prescription of concomitant doses).
231. Id. at 10 (including greater emotional and behavioral issues and greater severity of mental health
issues).
232. Id. at II (resulting in a lack of a consistent caretaker to plan treatment, offer consent, and
provide oversight).
233. Id. at 12 (noting a lack of collaboration among state agencies, as well as the consent process for
foster children, which may require the consent of multiple individuals or organizations).
234. U.S. GOV'T ACCOUNTABILITY OFFICE, GAO-\3-15, CHILDREN'S MENTAL HEALTH: CONCERNS
REMAIN ABOUT ApPROPRIATE SERVICES FOR CHILDREN IN MEDICAID AND FOSTER CARE I (2012)
[hereinafter U.S. GAO, CHILDREN'S MENTAL HEALTH].
235. Id. at 14.
236. Id. at 15.
237. Id.
238. Id.
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in their living placements that can lead to a lack of continuity in their mental health
care. 239 The frequent changes in residence lead foster children to have greater
difficulty establishing relationships and bonding with adults, adding yet another
stressor to these children. 24o
The American Bar Association ("ABA") Center on Children and the Law has
also analyzed the challenges faced by foster children.241 Their report acknowledges
that foster children often experience abuse and neglect, some witness violence and
trauma, others face parents with their own profound mental health issues. 242
Identified risk factors that increase these vulnerabilities include poverty,
neighborhood violence, racial discrimination, lack of food, and homelessness.243
This begs the question: are these children prone to developing mental disorders, or
are the traumatizing events in their lives creating the illusion of mental illness? Is it
nature or nurture that accounts for the higher rate of mental illness diagnosis and
subsequent prescriptions of isotropic medication?
The ABA report also expresses concern that foster children are more
vulnerable to improper psychotropic medication. 244 Factors that exacerbate such a
situation include living in group-care, being hospitalized in psychiatric inpatient
units, and being incarcerated. 245 The ABA provides possible explanations for the
higher use of psychotropic medication in this population, including that mental
health professionals more frequently come in contact with these children in
psychiatric treatment facilities, leading to greater opportunities to medicate. 246 Also,
children living in foster homes may be more susceptible to medication being used
to control their behavior to avoid transfers to more restrictive settings, such as in
group homes and residential training centers.247 There may also be pressure on
social service agencies to keep children in less expensive foster home settings, and
obedient behavior by foster children may result in the increased willingness of
foster parents to continue caring for the children in their foster home. 248 Whatever
the reason, the overmedication of such vulnerable children is clearly alarming.
Various states have found children in foster care are medicated with
psychotropic medication at higher rates. 249 A Texas study revealed that foster

239. Id. at n.55 (finding that foster children moved an average of 1.6 times in an eighteenth month
period, with some children changing placements as many as twelve times in the same period).
240. U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 15.
241. SOLCHANY, supra note 46, at I.
242. Id. at 3.
243. Id. ("Regardless of what led to their involvement in the child welfare system, all face separation,
broken relationships, and confusion.").
244. Id. at 14.
245. Id. (citations omitted).
246. Id.
247. See SOLCHANY, supra note 46, at 14 (describing generally how "children in foster care are
vulnerable to inappropriate or excessive medication use").
248. See id. at 4 (cautioning that "if caregivers are not adequately trained and educated in caring for a
child with significant emotional and psychological needs, medications can often be given to the child to
'manage their behaviors' rather than to truly treat the child's illness").
249. See U.S. GAO, FOSTER CHILDREN, supra note 222, at 8 ("Foster children in Florida,
Massachusetts, Michigan, Oregon, and Texas were prescribed psychotropic drugs at rates 2.7 to 4.5
times higher than were non foster children in Medicaid in 2008.").
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children enrolled in Medicaid were 3.5 to 11 times as likely to receive psychotropic
medication than other children enrolled on Medicaid250 The study revealed other
alarming data among the foster children receiving psychotropic medication: 41.3%
received three or more different classes of drugs and 15.9% received four or more
different classes of drugS. 251 The most frequently used medications were
antidepressants (56.8%), attention-deficitlhyper activity disorder drugs (55.9%),
and anti-psychotic agents (53.2%).252 This alarming concomitant use raises many
questions as to the necessity of this approach. According to testimony of Julie
Magno Zito before the House of Representatives Ways and Means Committee in
May 2008,253 there is little evidence of effectiveness or safety in the concomitant
psychotropic medication patterns for children in foster care. 254 Professor Zito
recommended individualized patient record review when three or more
psychotropic medication classes are given to children concomitantly.255 Her report
also highlighted the recommendation from the American Academy of Child and
Adolescent Psychiatry ("AACAP"), calling for more frequent monitoring of the
health care status of children in foster care placement than for children residing in
stable homes with parents. 256
The National Survey of Child and Adolescent Well-Being ("NSCA W")
examined the use of psychotropic medications for children in foster care through
the child welfare system.257 A striking finding is the disparity of psychotropic
medication use rates when children are placed in-home versus out-of-home, at
11 %, and 17.7%, respectively. 258 The high rate of medication use in out -of-homeplacements should concern all providers of child welfare services to children in the
foster care system. The findings of this study suggest that entry into foster care
serves as a "gateway for children to access specialty mental health services."259
Such entry tends to increase the child's likelihood of receiving psychopathic
treatment. 260
The Administration for Children and Families of the U.S. Department of

250. Zito et aI., supra note I, at e 157.

251. Id.
252. Id.
253. See Prescription Psychotropic Drug Use Among Children in Foster Case: Hearing Before the
Subcomm. on Income Security and Family Support of the H. Comm. on Ways and Means, II0th Congo
(2008) (statement of Julie M. Zito, Professor of Phannacy and Psychiatry, Phannaceutical Health
Services Research, University of Maryland, Baltimore).
254. Id. at 9.
255. Id. at 10.
256. Id. at 12.
257. See LEYLA F. STAMBAUGH ET AL., NATIONAL SURVEY OF CHILD AND ADOLESCENT WELLBEING, No. 17, PSYCHOTROPIC MEDICATION USE BY CHILDREN IN CHILD WELFARE 1-2 (2012)
(involving a longitudinal study of the well-being of 5873 children involved in the child welfare system
for a 14-month period starting in February 2008).
258. Id. at 3.
259. Id. at 6.
260. Cf Susan dosReis et aI., Mental Health Services for Youths in Foster Care and Disabled Youths,
91 AM. J. PUB. HEALTH 1094, 1094 (2001) (concluding that youths in foster care and youths receiving
Supplemental Security Income use more mental health services and are prescribed psychotherapeutic
medications more than youths in other aid categories).
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Health and Human Services ("HHS") also released an Information Memorandum
focused on oversight of psychotropic medication use in foster children. 261 Though
psychotropic medication usage among foster children is particularly distressing,
rates of psychotropic medication use among all children have increased. 262 A study
of psychotropic medication use in children revealed that "[b]etween 1996-1999 and
2004-2007, there was an approximately 75% increase in the proportion of child and
adolescent visits that mentioned a psychotropic medication (from 6.0% in 19961999 to 10.6% in 2004-2007).263 A plausible explanation for this increase is the
efforts of pharmaceutical companies to market drugs to prescribers and
consumers.264 This practice risks damage to the integrity of the psychiatric
profession. 265 With the increase in prescribing psychotropic medication for children
due to pressures from the pharmacy lobby, are our children receiving significant
increases in diagnoses of mental illness for the purpose of selling and distributing
more psychotropic medication to them? Are children's mental health needs being
dictated by the pharmaceutical industry?
Children's use of antipsychotic medication has also seen an increase in recent
years.2 66 There has been a worrying surge in the use of antipsychotic medication
being prescribed off-label. An off-label prescription is where medication is
prescribed for conditions and in populations that are not included in FDA-approved
labels. 267 Off-label prescriptions create safety concerns, including the possibility of
receiving ineffective medication, receiving dosages that are too high or too low, or
presenting side effects that are unique to children. 268 Not surprisingly, in 2007,
children on Medicaid who were in foster care were prescribed antipsychotic
medication at a significantly higher rate than non-foster children on Medicaid. 269 Of
particular concern to the GAO is the realization that drug manufacturers do not
always test medications for use on children, and that physicians can prescribe these
medications off-label to children. 270
261. Memorandum from the Admin. for Children & Families, U.S. Dep't of Health & Hum. Servs.
on the oversight of Psychotropic Medication for Children in Foster Care (Apr. 11,2012), available at
http://www.acf.hhs.gov/programs/cb/resource/imI203.
262. U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 10.
263. Jonathan S. Comer et aI., National Trends in Child and Adolescent Psychotropic Polypharmy in
Ojjice-Based Practice, 1996-2007,49 J. AM. ACAD. CHILD. & ADOLESCENT PSYCHIATRY 1002, 1005
(2010).
264. John Walkup et aI., Practice Parameter on the Use of Psychotropic Medication in Children and
Adolescents, 48 J. AM. ACAD. CHILD. & ADOLESCENT PSYCHIATRY 961, 962 (2009).
265. See Leemon McHenry, Ethical Issues in Psychopharmacology, 32 J. MED. ETHICS 405, 409
(2005) ("The integrity of medicine is endangered by an industry that profits from illness and distorts the
process of scientific inquiry by marketing strategy, public relations campaigns, and the sheer power of
buying influence in high places.").
266. U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 2.
267. See Stephen Crystal et aI., Broadened Use of Atypical Antipsychotics: Safety, Effectiveness, and
Policy Challenges, 28 HEALTH AFFAIRS w770, w773 (2009) (finding that, in 2004, almost 75% of
"children enrolled in Medicaid who were taking antipsychotic medication were diagnosed with
conditions for which there was no FDA indication").
268. SUSAN THAUL, CONGo RESEARCH SERV., RL33986, FDA'S AUTHORITY TO ENSURE THAT
DRUGS PRESCRIBED TO CHILDREN ARE SAFE AND EFFECTIVE 3 (2012).
269. U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 12.
270. [d. at 12-13.

148

TEMPLE POLITICAL & CIVIL RIGHTS LAW REVIEW

[Vol. 23:1

In particular, the extremely high use of antipsychotic medication for children
on Medicaid, which is twice the rate for privately insured children,271 revealed other
troubling findings. Many children who took antipsychotic medication did not
receive other mental health services, such as psychosocial therapy or counseling,
within that same year.272 The AACAP acknowledges that medication alone is rarely
an adequate treatment for children with complex mental health needs.273 The overreliance on psychotropic medication for children and the lack of face-to-face
professional mental health counseling services is another indictment of the mental
health system for children. 274 Oversight for the administration of psychotropic
medication to children is badly needed, and is beginning to be called for by
government agencies and oversight committees. 275 Social service agencies, mental
health agencies, and federal and state funding sources should coordinate their
efforts to remedy the catastrophe that has fallen upon children in the mental health
care system, particularly upon the vulnerable foster care population.276
B. An Oversight System Should be Created to Monitor the Children's Mental
Health System
Greater scrutiny is warranted for the instances where a government agency,
usually a local department of social services, becomes involved in the removal of
children from parents due to allegations of abuse, neglect, or abandonment. This
need for oversight is demonstrated by the overmedication of these vulnerable
children. A cautious approach when a local government social service agency
intervenes is not unusual. In Maryland, an application by a parent or guardian on
behalf of a child for admission into a psychiatric in-patient facility is permissible. 277
When the child is in the care of a social service agency, however, the voluntary
application process is prohibited. Application for admission to such a facility by a
minor in foster care under a social service agency is limited to the involuntary
admissions process.278 Having more stringent oversight and more stringent judicial
authority over these decisions is based in part on the historical concern that social

271. See id. at 19 (finding that, overall, "1.3% of children in Medicaid and 0.5% of privately insured
children took antipsychotics" and that the majority of children who took an antipsychotic were males
ages six to seventeen).
272. Id.
273. Id.
274. See id. at 37 ("Our analysis of national survey data indicates that concerns raised by providers,
children's advocates, and others about potentially inappropriate prescribing of psychotropic drugs for
some children and a lack of needed mental health services for some children may be warranted.").
275. See Fostering Connections to Success and Increasing Adoptions Act of 2008, 2008 Cal. Stat.
110-351 (calling for health care service oversight for children in foster care including oversight of
prescription medications); see also U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 29.
276. See U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 37 ("Nonetheless, these
findings do suggest that the recent federal and state initiatives to improve monitoring and oversight are
appropriate, and that continued assessment of the prescribing of psychotropic medications to vulnerable
populations and of the receipt of mental health services is important.").
277. MD. CODE ANN., HEALTH-GEN. § 10-610(c)(4)(ii)(West 2009).
278. See § 10-613 (establishing that admissions of minors to state facilities are involuntary
admissions unless otherwise provided for under Part 11 of the statutes).
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service agencies may abuse the voluntary admissions process out of convenience
rather than based on mental health needs for such in-patient care or treatment. Such
additional burdens and requirements appear justified for the vulnerable foster care
population, both in terms of in-patient hospitalization as wel1 as the prescribing of
psychotropic medication to these children.
Due to the documented overmedication of foster children, as wel1 as the
increasing use of psychotropic medication to treat mental1y il1 children in general,
there is growing demand for improved patient, family, and caregiver education,
govemmental oversight, and provider reporting. AACAP makes the fol1owing
recommendations for the use of psychotropic medication with children and teens: 279
1.
2.

3.

4.
5.
6.
7.

8.

9.
10.
11.
12.
13.

Before initiating pharmacotherapy, a psychiatric evaluation is completed;
Before starting pharmacotherapy, a medical history is obtained, and a
medical evaluation is considered when appropriate;
The prescriber is advised to communicate with other professionals involved
with the child to obtain col1ateral history and set the stage for monitoring
outcome and side effects during the medication trial;
The prescriber develops a psychosocial and psychopharmacological
treatment plan based on the best available evidence;
The prescriber develops a plan to monitor the patient, short and long term;
Prescribers should be cautious when implementing a treatment plan that
cannot be appropriately monitored;
Prescriber provides feedback about the diagnosis and educated the patient
and family about the child's disorder, and the treatment and monitoring
plan;
Complete and document the assent of the child and the consent of the
caregivers before initiating medication treatment and at important points
during treatment;
The assent and consent discussion focuses on the risks and benefits of the
proposed alternative treatments;
Implement medication trials using an adequate dose and for an adequate
treatment period;
The prescriber reassesses the patient if the child does not respond to the
initial medication trial as expected;
The prescriber needs a clear rationale for using medication combinations;
Discontinuing medication in children requires a specific plan.

The AACAP recommendations include significant guidance on the need to
obtain assent of the child and consent of the caregivers before initiating medication
treatment, including the provision of risks and benefits as well as alternative
treatments. 280 The acknowledgment that both the child and caregiver are
meaningful participants in the conversation with the prescriber of the psychotropic

279. John Walkup et aI., Practice Parameter on the Use of Psychotropic Medication with Children
and Adolescents, 48(9) J. AM. ACAD. CHILD. ADOLESCENT PSYCHIATRY 961-973 (2009).
280. Id. at 967.
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medication is to be applauded.28I In addition, the recognition that combining
medications increases the risks to the child is an important admonishment that must
be recognized by all parties.282
Another important study examined the use of psychotropic medication of
children in state custody.283 The data revealed that state and county welfare
agencies have established a variety of means of providing consent for prescribing
psychotropic medication. 284 Of particular interest is the finding that court consent is
required prior to administering psychotropic medication to children in six states;
with judicial consent required prior to an antipsychotic being prescribed in
residential treatment centers in Massachusetts. 285 Although Massachusetts limits its
court procedure to specific antipsychotic medication, such an approach of court
authorization may be necessary to stem the tide of the troubling increase in
medication among the foster care population. 286 States should consider requiring
court approval prior to the administration of psychotropic medication to children
admitted into inpatient psychiatric hospital settings.287 At the same time a judge
approves the admission of foster children in psychiatric hospital settings, a
concurrent finding of approval or denial of the administration of psychotropic
medication should OCCUr. 288 Such judicial oversight for the foster care population
into the most restrictive hospital settings ensures greater oversight that should lead
to a decline in the psychotropic medication use of foster children.289 Hopefully,
alternative treatment plans, second opinions, and independent oversight will occur
281. See LAUREL K. LESLIE ET AL., TUFTS CLINICAL AND TRANSLATIONAL SCI. INST., MULTI-STATE
STUDY ON PSYCHOTROPIC MEDICATION OVERSIGHT IN FOSTER CARE 13-15 (2010) (describing the
challenges faced by states in the infonned consent and treatment decision-making processes, and the
various solutions implemented, which include greater participation by the child).
282. See U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 1-2 ("In addition, child
mental health advocates, providers, and researchers have expressed concern about the increase in the
prescribing of psychotropic medications for children, in part because there is limited evidence available
regarding short- and long-tenn safety and efficacy for some types of medications, particularly for
combinations of medications.").
283. See Naylor, supra note 58, at 175 (examining the means in which state and county child welfare
agencies provide consent for providing psychotropic medicine to youths in state custody).
284. Id. at 182.
285. Id.
286. See MASS. DEP'T OF MENTAL HEALTH, AUTHORIZING THE USE OF ANTIPSYCHOTIC
MEDICATIONS: QUESTIONS AND ANSWERS (describing a Massachusetts Rogers Guardianship and its
see
also
Joanne
Moses,
What
is
a
Rogers
Guardianship?,
limitations);
http://www.massguardianshipassociation.org/infonnation/guardianship-of-an-adult-2/rogersguardianship/ (last visited Oct. 27, 2013) (describing the types of treatment a court may consider). A
Rogers guardianship hearing is where "the court is being asked to authorize extraordinary treatment or
care, such as administering antipsychotic medications, admitting an adult to a nursing home facility, and
other medical care." Id.
287. See MASS. DEP'T OF MENTAL HEALTH, supra note 286 (describing how a judge decides
treatment by acting as substitute decision maker for Rogers Guardianships).
288. See Moses, supra note 286 (describing a Rogers guardianship hearing).
289. See Dependent Children. Psychotropic Medications: Hearing on A.B. 82 Before the S. Comm.
on Judiciary, 2009 Leg., 2009-2010 Reg. Sess., at I (Cal. 2009) ("In 1999, the [California] Legislature
passed SB 543 ... in response to concerns that foster children were being subjected to excessive use of
psychotropic medication, and that judicial oversight was needed to reduce the risk of unnecessary
medication.").
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when courts are required to approve psychotropic medications. 290
In addition, state monitoring of the use psychotropic medication is
necessary.291 Florida, Arizona, and Texas have oversight programs that are
highlighted in the Naylor study.292 The need for "[a]n effective centralized
psychotropic medication consent and oversight process also requires appropriate
enabling state legislation to establish who is capable of and responsible for
consenting for treatment for youth in state care" for proper consent protocols is also
recommended in the Naylor report.293
In an exhaustive and comprehensive study, the Tufts Clinical and
Translational Science Institute examined policies and practices concerning state
oversight of psychotropic medication for children in foster care. 294 The study begins
by acknowledging that over the past decade, psychotropic medication use in youth
(defined as ages two to twenty-one years) has increased two-three fold, and
concomitant use of psychotropic medication has increased 2.5-8 fold.295 The
explanations offered for the increase in the use of psychotropic medications among
youth in foster care include the demand by foster parents and schools,
reimbursement and time pressures in the health care system, how Medicaid will pay
for the medications, how school officials' need to control a child's behavior before
permitting the child to return to school, and pressure from foster parents to decrease
a child's behavioral issues to keep the child in the foster care home. 296
The Tufts study also identified "red flag" markers that states used to identify
safety and equality of care issues. 297 The most common red flags include use of
psychotropic medication in young children, use of multiple psychotropic
medications concomitantly (usually three to five medications), dosage exceeding
current maximum recommendations, or dosage that are not consistent with state
guidance, and the failure to document or discuss the risks and benefits of the

290. See U.S. GAO, CHILDREN'S MENTAL HEALTH, supra note 234, at 24 (concluding that the state
of Washington's Second Opinions program resulted in an increase in referrals for psychosocial therapy
and a decrease in prescribing of antipsychotic medications); LESLIE ET AL., supra note 281, at 13 (listing
states' solutions to problems with informed decision-making/consent and appropriate medication
monitoring for foster care youth, which included the formulation of second opinions for complex cases).
291. See Naylor, supra note 58, at 186-87 ("A psychotropic medication consent program that
provides effective lon'gitudinal oversight of a youth's care, monitoring of prescribing patterns, and
consultative and educational services for foster parents, childcare workers, and caseworkers has several
potential benefits. ").
292. See id. at 184 (noting that Florida provides an update to the court regarding the child's medical
and behavioral status, Arizona offers guidelines for prescribing psychotropic medication to children,
Texas established a panel of child and adolescent psychiatrists, psychologists, and other mental health
professionals to develop best practice guidelines).
293. Id. at 187.
294. LESLIE ET AL., supra note 281, at I.
295. See id. (additionally finding that "[e]stimated rates of psychotropic medication use for youth in
foster care ... are much higher (ranging from 13-52%) than those for the general youth popUlation
(4%)" (footnotes omitted)).
296. Id. at 4.
297. Id. at 7 (explaining that red flag markers are used by states in their audits and case reviews,
resulting in promoting case reviews, ordering lab work, initiating prior authorization, and identitying
individual prescriber outliers).
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medications. 298
State oversight systems, as highlighted in the Tufts report, include such
components as access to up-to-date guidelines on clinical practices, informed
decision-making and consent and appropriate medication monitoring for individual
youth in foster care, involvement of biological parents and youth in ongoing
decision-making, oversight programs for monitoring trends and a national approach
and resources for psychotropic medication oversight. 299 States vary considerably
about who has the authority to give informed consent. 300 This reflects the rather
complex and challenging issue of who is granted the authority to consent to the
prescribing of psychotropic medication to foster children.
Three suggestions are offered to address the prescribing of psychotropic
medication to foster children. 30 ] First, children age sixteen years and older should
be permitted to consent or refuse the administering of psychotropic medication.
Second, for foster children hospitalized in a psychiatric setting, an administrative
law judge should conduct a hearing concurrently with the hearing on the
administration into the psychiatric facility to authorize the administration of
psychotropic medication. Third, a state oversight program should be created to
monitor and track the prescribing of psychotropic medication of foster care
children. Whenever more than one psychotropic medication is prescribed, the
oversight program shall be notified immediately.
C. Psychotropic Medication for Children is No Magic Bullet

In his accomplished book, Anatomy of an Epidemic, Robert Whitaker rails
against the psychiatric and pharmacological industry that he claimed has given rise
to mental illness in America. 302 Whitaker challenges the conventional wisdom that

298. Id.
299. LESLIE ET AL.,supra note 281, at 8.
300. See id. at 14 (explaining that in two states, the authority is with the prescriber, foster parent, and
youth; in other states the authority lies with the child welfare agency; some states use an external agency
for expert review; two states use the court system).
301. See TENN. DEP'T CHILD. SERV., ADMINISTRATIVE POLICIES AND PROCEDURES: 20.24, 5 (2011)
available at http://www.state.tn.us/youthldcsguide/policies/chap20/20.24.pdf ("When the need for
psychotropic medication arises, the parent(s) should be engaged in all medication decisions and
appointments for the child, unless ... the youth is 16 years of age or older."); see N.Y. MENTAL HYG. §
33.21(e)(2) (McKinney 2011) ("A minor sixteen years of age or older who consents may be
administered psychotropic medications without the consent of a parent or guardian or the authorization
of a court .... "); Moses, supra note 286 ("However, a Guardian does not have the power to consent or
withhold consent for the use of antipsychotic medications for their Incapacitated Person. A special
procedure is required to protect the Incapacitated Person. If the Incapacitated Person is being treated
with, or it is being proposed to treat this person with antipsychotic medications, the guardian must obtain
court authorization at a court hearing. If the Court authorizes such treatment, it will issue an order called
a "Rogers" order for treatment with antipsychotic medication."); George H. Sheldon et aI., Letter to
State Directors o/Child Welfare, ADMIN. FOR CHILD. & FAM., U.S. DEP'TOF HEALTH & HUM. SERV., 26
(Nov.
23,
2011),
(out Iin ing
https:llwww.childwe Ifare. govIsystemwide/mentalhea Ithleffecti veness/j ointlettermeds. pdf
steps that can be taken by state child welfare agencies to improve psychotropic medication oversight).
302. ROBERT WHITAKER, ANATOMY OF AN EPIDEMIC: MAGIC BULLETS, PSYCHIATRIC DRUGS, AND
THE ASTONISHING RISE OF MENTAL ILLNESS IN AMERICA 5 (2010) ("[A]s the psychopharmacology
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mental illness is a result of chemical imbalances in the brain and that psychotropic
medication can improve a person's mental health. 303 Whitaker asserts that the
precise causes of mental health are unknown. 304 He argues that psychiatrists
embraced the chemical imbalance theory of mental disorders "because it set the
stage for them to become real doctors."305 As doctors of internal medicine have
antibodies, now psychiatrists could have their "anti-disease" pills toO.306
There is a growing chorus of voices ringing the iatrogenic process bell,
asserting that doctors, through their choice of medical treatment, inadvertently
induce mental illness. 307 Yale psychiatrist Thomas McGlashan questioned whether
antipsychotics were making patients "more biologically vulnerable to psychosis"
and wondered whether the cure was worse than the disease. 308 Whitaker warns that
antipsychotic medication may actually make some patients with the diagnosis of
schizophrenia more "vulnerable to future relapses than would be the case in the
natural course of the illness. "309 Whitaker asserts "drugs were escalating the
likelihood that a person who suffered a psychotic break would become chemically
i11."310 He follows that initial exposure to neuroleptics puts patients on a path to
lifelong drug dependence311 and relapse suffered by patients withdrawn from
antipsychotics were drug-related and not the result of the disease.312
Whitaker also focuses his outcry on the impact the use of psychotropic
medication has on children.313 When Prozac, an antidepressant, was introduced,
"[t]he percentage of children so medicated tripled between 1988 and 1994, and by
2002, one in every forty children under the age of nineteen in the United States was
taking an anti-depressant."314 In addition, the number of children discharged from
hospitals with a bipolar diagnosis rose fivefold between 1996 and 2004, striking
one in every fifty prepubescent children in America.315 According to Whitaker, this
epidemic came of age; with the rise is lockstep with the prescribing of stimulants
and antidepressants to children. 316
The iatrogenic epidemic, reports Whitaker, accounts for "400,000 bipolar
children arriving via the ADHD doorway, and at least another half million through

revolution has unfolded, the number of disabled mentally ill in the United States has skyrocketed.
Moreover, this increase in the number of disabled mentally ill has accelerated further since the
introduction of Prozac and the other second-generation psychiatric drugs").
303. [d. at 10-11.
304. [d. at 332.
305. Id. at 78 (internal quotation marks omitted) (citation omitted).
306. Id.
. 307. See id. at 71-85 (describing the evidence that chemical imbalances in the brain cause mental
health problems, such as depression and schizophrenia, and that medications designed to treat these
supposed imbalances induce the problems that the medications were designed to treat).
308. WHITAKER, supra note 302, at 114.
309. Id. at 104 (citation omitted).
310. Id.
311. [d. at 106.
312. [d.
313. Id. at 216-17.
314. WHITAKER, supra note 302, at 229.
315. [d. at 235.
316. [d.
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the antidepressant doorway."317 Whitaker notes that foster children are now
regularly diagnosed with bipolar disorder, their symptoms not the result of having
been born into dysfunction, but "rather due to biological illness."318 He also asserts
that teenagers involved in the criminal justice system are "regularly funneled into
psychiatric roles," adding to the bipolar numbers.319 Even the very young child is
affected; the number of severely mentally ill children under six years of age
receiving Supplemental Security Income ("SSI") has tripled, recently rising from
22,452 in 2000 to 65,928 in 2007. 320 An alarming piece of data reported by the
GAO in 2008 is that one in every fifteen young adults, ages eighteen to twenty-six,
and is now "seriously mentally ill."321 Whitaker shines the spotlight directly on the
misuse of the prescribing of psychiatric drugs to children and adolescents over the
past twenty years, which has become so commonplace that it is putting "millions
[of children] onto a path of lifelong illness."322 There must be a dialogue within the
psychiatric, social work, and legal communities to explore alternative forms of nondrug treatment options and recognize the limits of medication in the treatment of
mental illness.323 The speed at which physicians tend to diagnose children with
mental illness, often during the initial examination of the child, leads to a lifetime
label and lifetime of medication and must be the centerpiece of a reform
movement. 324
III. STATISTICAL REVIEW AND ANALYSIS OF PSYCHIATRISTS AND PEDIATRICIANS'
VIEWS ON CONSENT, REFUSAL, AND MEDICATION OF MINORS

The empirical data provided in this article is submitted to demonstrate the
views and opinions of psychiatrists and pediatricians who treat mentally ill children
with psychotropic medication. To provide empirical data on the perspective of
psychiatrists and pediatricians about the consent procedures for children, and
procedures governing a minor's refusal to take psychotropic medication, this author
surveyed a diverse group of thirty-five psychiatrists and pediatricians.325 The

3 I 7. [d. at 239; see id. at 242 (explaining how "[f]ifty years ago, physicians virtually never saw
manic-depressive illness in preteens"; however, after physicians started prescribing Ritalin to
hyperactive children, there were reports of manic children).
3 I 8. [d. at 242.
319. WHITAKER, supra note 302, at 242; see id. at 245 (noting that a child who is hyperactive or
depressed is treated with a drug that triggers a manic episode and becomes a child put on a drug cocktail,
leading to a lifetime of disability).
320. [d. at 245.
32 I. [d. at 245-46.
322. [d. at 246.
323. See id. at 33 I -59 (calling for a conversation about the role of psychotropic medications, a
refonned mental health care system, and new treatments for mental health concerns).
324. See WHITAKER, supra note 302, at 220. 224, 234-37, 246 (discussing the rapid rise in the
number of children diagnosed with ADHD and bipolar disorder over the past few decades and the
likelihood that the medications used to treat such conditions only cause worse mental health problems).
325. See Donald H. Stone, Children & Psychotropic Medications: Psychiatrists (2013) [hereinafter
Stone Survey] (unpublished web-based survey conducted by the author), available at
https://www.surveymonkey.com/s.aspx?sm=q31%2bAQzUkEF%2fnkHnVSW9Hw''103d%3d.
The
survey questions are listed in Appendix B.
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respondents to the survey were psychiatrists or pediatricians from a variety of
settings, public and private, inpatient and outpatient.326 The survey highlighted the
treatment and consent issues involving children in the foster care system, which
revealed an important perspective surrounding the reasons for the overmedication
of foster care children.327 The empirical data 328 contained in this article is submitted
to serve as a backdrop for purposes of illuminating and understanding the consent
issue, medication refusal issues, as well as the challenges in prescribing
psychotropic medication for minors.
When mentally ill children are removed from their parent and placed in the
care of a social service agency and treated in an inpatient psychiatric facility, there
is a need to provide informed consent for psychotropic medication.329 There is an
even split between consent provided by the parent and consent provided by a social
services caseworker. 330 On the one hand, a child removed from their home due to
abuse or neglect may trigger a need for a substitute decision maker; on the other
hand, the social service agency may desire to keep the parent involved by
permitting them to continue to make treatment decisions.331
At the time physicians prescribe psychotropic medication to children and prior
to obtaining informed consent, certain information regarding the psychotropic
medication is provided to the party giving consent. The survey inquired about a
variety of information about the medication to enable the person providing consent
to understand the options and reasons for medication in order to provide an
informed and knowledgeable consent prior to the medication being administered.
Of the thirteen items included, the top three areas of information include adverse
reactions, benefits and intended outcomes, and diagnosis and targeting
symptoms.332 The least likely information offered include: explanation of procedure
if consent is not obtained, FDA status of the medication, and frequency range. 333

326. Id.
327. Id.
328. Id. The percentage cited in this article represents the percentage of valid responses to each
question, which exclude participants who did not respond.
329. Naylor, supra note 58, at 179-80.
330. See Stone Survey, supra note 325, at Question 4 (noting that when an emergency exists, the
infonned consent process is overridden by the physician).
331. See Naylor, supra note 58, at 176, 179-83 (noting that states have established various consent
procedures involving either parents or government officials for children in state custody).
332. Stone Survey, supra note 325, at Question 5.
333. Id. at Question 5.

PflorlO obtaining Informed eonsent, what informatlon do you provide to the party giving
consent? Please check all that apply.
~,------------------------------------------------------------

The respondents were asked whether they utilize a standardized consent fonn
prior to prescribing a psychotropic medication to a minor. 334 Eighty-one percent
answered no. It is strongly recommended that a standardized consent fonn be
utilized, including the important criteria as highlighted in Survey Question 5. A
model standardized consent fonn is included in Appendix B.
Another important issue included in the survey involves the procedure to
override a minor's refusal to take psychotropic medication while a patient is in an
inpatient facility. In several states, state law dictates the procedure for overriding a
minor's refusal. 335 In some states, a parent or legal guardian is called upon to
consent to psychotropic medication and the voice and opinion of the minor is
disregarded. 336 However, there is a growing sentiment for mature minors, at age
sixteen and above, to be consulted and heard on the matter of psychotropic
medications. 337 When a minor at age sixteen refuses to consent to psychotropic
medication at an inpatient facility, the procedure for overriding such minor should
be the same as that one which is utilized for adult psychiatric inpatients and which
is spelled out in state law. 338 It is urged that the same procedure followed for adults
334. [d. at Question 6.
335. See, e.g., ARIZ. DEPT. OF HEALTH SERYS., supra note 196.
336. See John A. Menninger, Involuntary Treatment: Hospitalization and Medications 5, available at
http://www. brown.edu/Courses/BI_278/0ther/Clerkship/Didactics/Readings/INVOL UNT ARY%20TRE
ATMENT. pdf (unpublished manuscript) (explaining that parents, regardless of their children's wishes,
typic
ally have the right to consent to their children's medical procedures).
337. See Christopher O'Connor, What Rights Do Minors Have to Refuse Medical Treatment?, 4 1.
LANCASTER GEN. Hasp. 63, 63-64 (2009), available at http://www.jlgh.orgiPast-Issues/Volume-4--Issue-2/Medico-Legal-Matters.aspx (noting that physicians often wish to respect the privacy rights of
minors by allowing them to make their own medical decisions).
338. See, e.g., MD. CODE ANN. HEALTH-GENERAL § 10-708 (West 2009) (allowing an adult in
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who refuse psychotropic mediclltim be expanded to minors at age sixteen and
above. m The Survey solicited views on this logic, including who participates when
minors refuse; the most often mentioned individuals include the treating
psychiatrist, social services case worker, and parent or guardian. 3'0
III all

if il mlllor refuus to tiIl<e II prescribed
!')svenotrOl1,ie mildiiwj,ol'l? Cheekall that apply.

Maryland to refuse medication unless the individual is either in the midst of an emergency situation or
has been voluntarily committed and the medication has been approved by a clinical review panel).
339. See id. (defining the process by which adults in Maryland may refuse mental health medication).
340. Stone Survey, supra note 325, at Question 10.
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When psychiatrists and physicians were asked for their opinion as to at what
age a minor should have the right to refuse the administration of a psychotropic
medication, age sixteen and above was the most common response. 341
In your opinion, shoold a minor haye the right to refuse the 1Idminlstrlrtlon of a psychotroPIc
medlcarlcn11f so. should thal right be limited by the .ge of the mInor"!

10

34l. Id. at Question 13.
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The procedure for overriding a minor's refusal to consent to psychotropic
medication should be resolved by an independent judicial hearing rather than by a
process seen by the hospital, recommending the independent system two to one. 342
In your opinion, who should govern the procedure overriding a minar's refusal to
consent to psvchotropic medications?

342. Id. at Question 14.
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Another controversial issue surveyed addressed the question of whether the
treating physician prescribing the psychotropic medication relied on a list of
approved medications for use on minors. 343 Rather surprisingly, eighteen of twentyseven answered no. 344
00 you rely on a list of approved psychotropic medicallons for use In minors? If so, who
provides this list? Check all that apply.

Another recommendation is state oversight of psychotropic medication of
children. There is a need for physicians to report certain information to a statemonitoring agency.345 Mandated reporting should include:
1.
2.
3.
4.

Prescribing psychotropic medications to children under five;
Prescribing multiple psychotropic medications within the same drug
class;
Prescribing medication to minors that exceeds a dosage exceeding
FDA limits;
Prescribing medication not approved for use in children.

343. Id., at Question 15.
344. Id.
345. See Naylor, supra note 58, at 183-85 (noting that some states provide oversight of psychotropic
medications administered to minors in state care by requiring all responsible adults overseeing the
child's case to participate in the treatment plans and providing programs dedicated to reviewing the
assigning of psychotropic drugs to minors).
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In the following chart, yon may choose more than one response. For reasons explained below, I
have prescribed psychotropic medication to a child that . ..
It was

No other
The practice is
This
the hest
medications practice
approved by a
represents hospital andlor
medication were
for the
available.
the
medical practice
symptoms
standard group.
presented.
of care.

The practice is
approved by a
government
agency.

The practice N/A
is approved
by a
professional
association.

56.7%

33.3%

66.7%

16.7%

6.7%

33.3%

33.3%

... exceeded
48.3%
dosage
recommendation
s.

20.7%

34.5%

6.9%

3.4%

17.2%

48.3%

... exceeded more 46.7%
than two
psychotropic
prescriptions for
an individual
child.

16.7%

46.7%

13.3%

6.7%

23.3%

50.0%

... exceeded more 37.9%
than one
psychotropic
medication in a
particular drug
class.

17.2%

34.5%

6.9%

3.4%

17.2%

55.2%

... was under five 46.7%
years of age.

26.7%

33.3%

10.0%

6.7%

33.3%

50.0%

... was not
recommend-ed
by the FDA for
use in minors .
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If you were examlnlns a minor p*11t for tire first time, whi<:1l of tile following existing oondi1!on"

would. <iiluse YOIl <:OI1ctm? el1$el\ all tIl;!1 lIPPIy,

The recommendations above were highlighted in the survey responses as
concerns by those responding. 346 When questions on the survey focused specifically
on foster children, the higher rates of medication for foster children is indicated. 347
Eight respondents had significant concerns, however eight indicated there were
reasonable explanations for the procedure.

346. Stone Survey, supra note 325, at Question 18. The top response was minors on multiple
medications within the same drug class. See id. at Question 19 (reporting, however, is rarely mandated).
347. Jd. at Question 20.
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R.~ s1udies. indi¢ate thllt foster chlldl'fln al'fl prescrlbfld psycl'lotroplc MfldieatiOlls lit hlQIlfIr
rates thlll'! children II'! their JllI!'iInt's. carll. Hllve yQtI noticed this practice? PI_ US& the "othern
box for further ,."planation"

The reasons why children in foster care are medicated at higher rates than nonfoster children complex. The primary reason explained in the survey responses is
the lack of stability and frequent moves associated with being in foster care. 348
Other reasons include more contact with psychiatrists and treatment facilities,
referrals by schools because of in school behavior, and more contact with the
criminal justice system. 349

348. Jd. at Question 21.
349. Id.
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If you have notic:ed higher rates of psychotropic medication use In foster children, why, in your
opinion, is tIlis happening? Check all that apply.

Clearly, the ovennedication of foster children is a grave concern that should be
addressed by the health care, social service, and legal communities. 350 Alternatives
to psychotropic medication should be explored, and the ease with which parents
and social service agencies can override a minor's refusal to consent to
psychotropic medication should be restricted and more closely scrutinized.
CONCLUSION

No doubt, there are competing interests among the psychiatric community,
foster care system, and parents in the treatment of mentally ill children. States
should acknowledge the authority of mature minors in the right to consent to or
refuse psychotropic medication. All parties will benefit from a more informed
patient who is prescribed medication to treat a mental illness. Our vulnerable foster
care children should be particularly monitored by an independent body to scrutinize
the prescribing of psychotropic medication.
A spotlight must be pointed at the mental health system for children to shine
light on the process of medicating our mentally ill children. The risks and benefits
of psychotropic medication should be reviewed, the consent and refusal authority

350. Id.; see also Naylor, supra note 58, at 186-90 (noting that changes must be made to the process
of consenting to psychotropic medications, child welfare agencies should partner with academics to
develop better methods for monitoring psychotropic medications, legislators need to draft laws to better
ensure such oversight, and caseworkers and clinicians should work to ensure that there is a better system
to research policies about consent and psychotropic medications).
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should be more clearly articulated, and hopefully all children with mental illness,
particularly foster children, will benefit.
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Appendix A: Sample Consent Form
Authorization to Administer Psychotropic Medications
Informed Consent Form

Child's Identifying Infonnation:
Child's Name:
Date of Birth:
Sex:
Height:
Weight:
Prescribing Health Care Provider:
Name:
Facility Name:
Address:
Tel. Number:
Setting:
_Psychiatric Hospital
_RTC
_Foster or Group Home
_Shelter
_Outpatient Facility
_Detention Center
_Other
Reason for Request:
_Continue Current Medication Only
_New Medication
_Dosage Adjustment
_Emergency Use (PRN Order)
_Other
If hospitalized, patient is admitted as a:
_Voluntary Admission
_Involuntary Admission
Clinical Reason for Request:
DSM-5 Diagnosis:
Allergies/Adverse Reactions:
Current Psychotropic Medications:
Medication:
1. Dosage:
2. Administration Schedule:
Medication:
1. Dosage:
2. Administration Schedule:

[Vol. 23:1
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Current Non-Psychotropic Medications (including nutritional supplements):
Discontinued Psychotropic Medication:
New Medications: (add additional sheets if more than one new medication is
prescribed.)
Name of Medication:
DosagelFrequency:
Duration of Administration (not to exceed 90 days prior to review and renewal
period):
Target Symptoms:Benefits/lntended Outcomes:
Potential Side Effects:
Likely Results of Not Taking Medication:
TestslProcedures required before/during regimen:
Alternate Treatments (including reasons these treatments were rejected):
FDA Approval:
I agree that I have discussed the following information with my behavioral health
medical practitioner for each medication listed below:
· The diagnosis and target symptoms for the medication recommended;
· The possible benefits/intended outcome of treatment, and as applicable, all
available procedures involved in the proposed treatment;
· The possible risks and side effects;
· The possible alternatives, and the explanation of why each alternative was not
chosen;
· The possible results of not taking the recommended medication;
· The possibility that my medication dose may need to be adjusted over time, in
consultation with my psychiatrist, pediatrician, or other physician;
· My right to actively participate in my treatment by discussing medication
concerns or questions with my behavioral health medical practitioner;
· If I am a child 16 years old or older, or a parent or guardian of the child; my right
to refuse or withdraw voluntary consent for medication at any time;
·Prior to medication being administered involuntarily, the right to request an
administrative hearing.
I understand the medication information that has been provided to me. By signing
below I agree to the use of each medication.
Child, aged 16 or over
Parent/Guardian if child is under age 16

168

TEMPLE POLITICAL & CIVIL RIGHTS LAW REVIEW

[Vol. 23:1

Appendix B: Survey
1. Please fill in the following demographic information:

a. Is your primary specialty child psychiatry, adult psychiatry, or pediatrics?
b. What is your job title?
c. In what state do you practice?
d. How many years have you been a physician?
e. Gender?
f. In what type of facility do you practice? (public or private?)
g. In what type of setting do you practice (inpatient, outpatient, or both?)
h. What type of patients do you primarily come in contact with? (mainly children,
mainly adults, or both?)
i. Do you treat foster children? (often, occasionally, rarely, never)
j. Approximately how many children have you seen as patients in the past 12
months? (1-10, 11-25,26-50,50-100, over 100)

2. In an in-patient setting, when you prescribe a psychotropic medication to a
minor in the care of a social service agency, who provides informed consent?
a. Parent or Legal Guardian
b. Social Services Case Worker
c. Social Services Designated Medical Consent Officer
d. Court Official
e. Child (Please provide an age of consent, if utilized, in the comment box below)
f. Other (please specify)

3. In an out-patient setting, when you prescribe a psychotropic medication to a
minor in the care of a social service agency, who provides informed consent?
a. Parent or Legal Guardian
b. Social Services Case Worker
c. Social Services Designated Medical Consent Officer
d. Court Official
e. Child (Please provide an age of consent, if utilized, in the comment box below)
f. Other (please specify)

4. How does the informed consent process change if a psychotropic medication
is administered on an emergency, and foreseeably temporary, basis? (For
example, PRN orders)
a. Consent is not required for emergency situations
b. A lack of consent can be overridden by a physician or other medical professional
in emergencies.
c. Informed consent for the initial prescription includes a provision allowing
supplemental emergency prescriptions, as needed.
d. The informed consent process does not change for emergency prescriptions.
e. Other (please specify)
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5. Prior to obtaining informed consent, what information do you provide to
the party giving consent? Please check all that apply.

a. Adverse reactions
b. Alternative medications or treatments, and associated risks and benefits
c. Benefits/Intended outcome
d. Contraindications
e. Diagnosis and targeted symptoms
f. Dosage
g. Duration
h. Explanation of procedure if consent is not obtained (including consent override,
court order, etc.)
i. FDA status of the medication/level of evidence supporting the recommended
medication
j. Frequency range
k. Right to withdraw treatment by consenting party
I. Seek consent of child in addition to parent/guardian
m. Warnings or precautions
n. Other
6. Do you utilize a standardized consent form prior to prescribing a
psychotropic medication to a minor?

a. Yes (Answer Question 7)
b. No (Answer Question 8)
7. If a standard consent form is utilized, who developed the form?

a. Department of Social Services (City, County, or Local)
b. Department of Social Services (State)
c. Other Government Agency (Explain below)
d. Insurance Provider
e. Professional Association (Explain below)
f. Other (please specify)
8. If a standard consent form is not utilized, do you follow a consent policy?

a. Yes, provided by the medical facility.
b. Yes, provided by a state government agency
c. Yes, provided by a county, city, local, or agency
d. Other (please specify)
9. In an in-patient setting, is there a procedure to override a minor's refusal to
take psychotropic medication, similar to procedures established when an adult
refuses to take psychotropic medication?

a. Yes, as provided by state law
b. Yes, as provided by hospital policy
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c. No, there is no process in place. As the treating psychiatrist, I am free to make
that determination based on the circumstances
d. Other (please specify)

10. In an in-patient setting, who participates in the process governing a
minor's refusal to take psychotropic medication? Check all that apply.
a. Attorney
b. Clinical Director
c. Guardian ad litem
d. Minor
e. Other mental health professional
f. Parent or legal guardian
g. Social Services case worker
h. Treating psychiatrist
i. Other (please specify)

11. In an in-patient setting, when a minor refuses to take a psychotropic
medication, who makes the final determination to resolve the outcome of that
case?
a. Clinical or Medical Director
b. Judge (including Administrative Law Judge, Hearing Officer, etc.)
c. Other (please specify)

12. In an in-patient setting, what steps do you take if a minor refuses to take a
prescribed psychotropic medication? Check all that apply.
a. Abide by the minor's refusal to consent and take no further action
b. Facilitate a discussion to encourage the minor to provide consent
c. Obtain the consent of the parent or the minor's case worker to override minor's
refusal to consent
d. Obtain the consent of another official to override the minor's refusal to consent
(Specify below)
e. Forcibly medicate the minor
f. Seek a court order to medicate the minor
g. Other (please specify)

13. In your opinion, should a minor have the right to refuse the administration
of a psychotropic medication? If so, should that right be limited by the age of
the minor?
a. Yes, a minor of any age should be able to refuse a psychotropic medication
b. Yes, a minor 10 years of age or over should be able to refuse a psychotropic
medication
c. Yes, a minor 12 years of age or over should be able to refuse a psychotropic
medication
d. Yes, a minor 14 years of age or over should be able to refuse a psychotropic
medication
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e. Yes, a minor 16 years of age or over should be able to refuse a psychotropic
medication
f. No, only adults over the age of 18 should be able to refuse a psychotropic
medication
14. In your opinion, who should govern the procedure overriding a minor's
refusal to consent to psychotropic medications?

a. An independent judicial hearing, run by a government agency or court
b. A hearing within the hospital or treatment center, run by a hospital board or other
authorized group
c. Other (please specify)
15. Do you rely on a list of approved psychotropic medications for use in
minors? If so, who provides this list? Check all that apply

a. Yes, the hospital and/or medical practice group provides this list
b. Yes, a state agency provides this list
c. Yes, a county and/or local agency provides this list
d. Yes, an insurance provider provides this list
e. No
f. Other (please specify)
16. Do you rely on a list of recommended and/or safe dosage levels or
psychotropic medications for use in minors?

a. Yes, the hospital and/or medical practice group provides this list
b. Yes, a state agency provides this list
c. Yes, a county and/or local agency provides this list
d. Yes, an insurance provider provides this list
e. No
f. Other (please specify)
17. For reasons explained below, I have prescribed psychotropic
medication to a child that ...

i. . .. was not recommended by the FDA for use in minors
ii .... exceeded dosage recommendations
iii .... exceeded more than two psychotropic prescriptions for an
individual child
iv .... exceeded more than one psychotropic medication in a
particular drug class
v .... was under five years of age
Answers
a. It was the best medication for the symptoms presented
b. No other medications were available
c. This practice represents the standard of care
d. The practice is approved by a hospital and/or medical practice group
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e. The practice is approved by a government agency
f. The practice is approved by a professional association
g. N/A

18. If you were examining a minor patient for the first time,
which ofthe following existing conditions would cause you concern?
Check all that apply.
a. The minor was on psychotropic medication(s) under the age of five
b. The minor was on multiple psychotropic medications, some of which
were within the same drug class
c. The minor was on a psychotropic medication with a dosage exceeding
FDA limits
d. The minor was on a psychotropic medication that was not approved
for use in children

19. Do you report data pertaining to psychotropic medications to any
organization?
a. Yes, to a state social services agency
b. Yes, to a county and/or local social services agency
c. Yes, to the state Medicaid agency
d. Yes, to the hospital board andlor the medical practice group head
e.No.

20. Recent studies indicate that foster children are prescribed psychotropic
medications at higher rates than children in their parent's care. Have you
noticed this practice? Please use the "other" box for further explanation.
a. Yes, and I have significant concerns
b. Yes, but there are reasonable explanations for this practice
c. No, I have not noticed this
d. Other (please specify)

21. If you have noticed higher rates of psychotropic medication use in foster
children, why, in your opinion, is this happening? Check all that apply.
a. Ease of Medicaid policies to prescribe medication
b. Discrimination on the basis of race or class
c. Foster parent's desire to keep children in the home
d. Lack of stability/frequent moves
e. More contact with the criminal justice or juvenile justice system
f. More contact with psychiatrists or treatment facilities
g. Referred by schools or teachers because of in-school behavior
h. Other (please specify)

